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Abstract 
Abnormal eating behaviour and metabolic parameters including insulin resistance, 
dyslipidaemia and body mass index are increasingly recognized as important 
components of neurodegenerative disease and may contribute to survival. It has 
previously been established that behavioural variant frontotemporal dementia is 
associated with abnormal eating behaviour characterised by increased sweet 
preference. In this study, it was hypothesized that behavioural variant frontotemporal 
dementia might also be associated with altered energy expenditure. A cohort of 19 
patients with behavioural variant frontotemporal dementia, 13 with Alzheimer’s 
disease and 16  (age- and sex- matched) healthy controls were studied using Actiheart 
devices (CamNtech, UK) to assess resting and stressed heart rate. Actiheart devices 
were fitted for 7 days to measure sleeping heart rate, activity levels, and resting, 
active and total energy expenditure. Using high resolution structural MRI the neural 
correlates of increased resting heart rate were investigated including cortical thickness 
and region of interest analyses. In behavioural variant frontotemporal dementia, 
resting (p=.001), stressed (p= .037) and sleeping heart rate (p=.038) were increased 
compared to controls, and resting heart rate (p=.020) compared to Alzheimer Disease 
patients. Behavioural variant frontotemporal dementia was associated with decreased 
activity levels compared to controls (p= .002) and increased resting energy 
expenditure (p= .045) and total energy expenditure (p=.035). Increased resting heart 
rate correlated with behavioural (Cambridge Behavioural Inventory) and cognitive 
measures (Addenbrooke’s Cognitive Examination).  Increased resting heart rate in 
behavioural variant frontotemporal dementia correlated with atrophy involving the 
mesial temporal cortex, insula, and amygdala, regions previously suggested to be 
involved exclusively in social and emotion processing in frontotemporal dementia. 
These neural correlates overlap the network involved in eating behaviour in 
frontotemporal dementia suggesting, a complex interaction between eating behaviour, 
autonomic function and energy homeostasis. As such the present study suggests that 
increased heart rate and autonomic changes are prevalent in behavioural variant 
frontotemporal dementia, and are associated with changes in energy expenditure. An 
understanding of these changes and neural correlates may have potential relevance to 
disease progression and prognosis. 
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Introduction 
Traditionally Frontotemporal dementia (FTD) has been viewed as a syndrome 
characterised by behavioural and cognitive changes, although increasingly it is being 
recognised that there is involvement of networks that affect physiological processing 
including somatosensory processing including pain and temperature (Fletcher et al., 
2015a; Fletcher et al., 2015b), autonomic processing (Ahmed et al., 2015a; Guo et al., 
2016), and neuroendocrine and metabolic changes (Ahmed et al., 2014b; Ahmed et 
al., 2015b). In behavioural variant frontotemporal dementia (bvFTD), eating 
behavioural changes are common, including hyperphagia, increased sweet preference 
and changes in food preference that may be associated with increased body mass 
index (BMI), dyslipidaemia and insulin resistance (Ahmed et al., 2014b).  
 
In several neurodegenerative diseases it is established that there are changes in 
metabolic parameters. One such condition is ALS, which shares a clinical and 
pathological overlap with FTD and where consistent changes have been found 
(Ahmed et al., 2016b), including increased resting energy expenditure in up to 50% of 
patients (Bouteloup et al., 2009; Vaisman et al., 2009). It has also been suggested that 
the hypermetabolic state (defined as increased energy expenditure) is intrinsically 
linked to the process of neurodegeneration with several animal models of TDP-43 and 
the C9ORF72 gene expansion exhibiting hypermetabolism and weight loss (Dupuis et 
al., 2004; Chiang et al., 2010; Shan et al., 2010; Xu et al., 2010; Koppers et al., 2015).  
 
Given the significant overlap between FTD and ALS at a clinical, pathological and 
genetic level, it seems plausible that changes in energy expenditure may also be 
present in FTD (Ahmed et al., 2016b). In addition, the changes in appetite appear to 
exceed the minor increments in BMI and weight gain seen in bvFTD, suggesting 
increased energy expenditure may also contribute to the body weight changes seen in 
patients (Woolley et al., 2007; Ahmed et al., 2014a).  This is also suggested by the 
fact that in studies measuring caloric intake in FTD, BMI does not correlate with 
caloric intake (Ahmed et al., 2016a). Energy expenditure, which includes basal 
metabolic rate (amount of energy expended at rest) and active energy expenditure (a 
combination of activity levels and heart rate), has not been investigated in bvFTD. 
Intrinsically linked with energy expenditure are potentially alterations in autonomic 
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activity including heart rate, heart rate variability, and sympathetic and 
parasympathetic drive (Messina et al., 2013). Changes in the autonomic nervous 
system, particularly in the sympathetic nervous system have also been proposed to 
affect glucose and fat metabolism (Nonogaki, 2000; Penicaud et al., 2000).  Increases 
in heart rate have been found to predict an increase in metabolic rate and energy 
expenditure, via an increase in circulatory rate and oxygen consumptions (Berggren 
and Hohwu Christensen, 1950).  
 
Measurement of energy expenditure in free-living individuals is challenging. In this 
study, we used digital heart rate/activity monitoring (Brage et al., 2004; Brage et al., 
2005; Crouter et al., 2008) to examine changes in heart rate (rest, stressed and sleep), 
activity levels and energy expenditure and the potential correlations that this has to 
autonomic function in a large group of bvFTD patients, compared to a disease 
comparison group (Alzheimer’s disease, AD) and healthy controls. This approach has 
been used previously in genetic obesity research but not in patients with 
neurodegeneration (Pearce et al., 2013). The potential neurobiological underpinnings 
of increases in heart rate were further examined using structural MRI imaging to 
provide insight into the neural correlates controlling energy expenditure and 
autonomic function in FTD.  
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Methods 
 
Participants 
Thirty-two patients with dementia (19 bvFTD, 13 AD) were recruited from Forefront, 
Neuroscience Research Australia. These individuals were compared with 16 age- and 
sex-matched healthy controls. All patients underwent neurological review, cognitive 
assessment and met current clinical diagnostic criteria for probable bvFTD or AD 
(McKhann et al., 2001; Gorno-Tempini et al., 2011; McKhann et al., 2011; 
Rascovsky et al., 2011). Disease severity was established using the Frontal Rating 
Scale (FRS) (Mioshi et al., 2010). Controls were recruited from the Neuroscience 
Research Australia Volunteer database. Healthy controls scored above 88/100 on the 
Addenbrooke’s Cognitive Examination-III (Hsieh et al., 2013) and 0 on the sum of 
boxes score of the Clinical Dementia Rating scale (Morris, 1993). Exclusion criteria 
for patients and controls included concurrent psychiatric disturbance, other 
neurodegenerative conditions or neurological disorders and/or history of substance 
abuse. 
 
Patient medical history and medications 
Patients medical records and list of medications were obtained from their general 
practitioner. Given that the study measured heart rate variations, patients with a 
known cardiac rhythm disorder e.g. atrial fibrillation, supraventricular tachycardia or 
conduction delays were excluded from the study (1 bvFTD and 1 AD patient).  
Patients, their carers and controls were asked about their current smoking status and 
alcohol intake. 
 
Ethics 
This study was approved by the South Eastern Sydney Local Health District and the 
University of New South Wales human ethics committees. Written informed consent 
was obtained from each participant and/or their primary caregiver. 
 
Physiological measurements: Actiheart device 
Participants were fitted with the Actiheart device (CamNtech, Cambridge, UK) a 
compact device designed to quantify heart rate, activity and energy expenditure 
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(Brage et al., 2004; Brage et al., 2005; Crouter et al., 2008). The Actiheart has two 
clips which are attached directly to standard ECG electrodes. One electrode was 
attached to V1 on the chest (4
th
 right intercostal space) and the second electrode was 
placed 10 cm away on the left mid-clavicular line. The number of R waves detected is 
recorded at 15-second epochs and from this the heart rate is derived. An internal 
triaxial accelerometer senses the frequency and intensity of the participant’s torso 
movements including walking and pacing from which activity counts are derived. 
When placed in short term mode, the Actiheart measures heart rate variability, heart 
rate and inter-beat interval (IBI) of the heart rate, with an epoch length of 15 seconds. 
Long term recordings in long term mode provide mean heart rate and activity levels 
over an epoch of 15 seconds and recordings can be made for up to 11 days (Brage et 
al., 2004; Brage et al., 2005; Crouter et al., 2008).  
 
Measurement of heart rate 
To measure resting and stressed heart rate participants wore the Actiheart in short 
term recording mode for a period of 6 hours following a standard protocol, described 
briefly. After arriving fasted (10 hours) and an initial period of introduction patients 
were given a set breakfast that measured caloric intake (Ahmed et al., 2016a), no 
caffeine or tea was included in this breakfast to avoid their chronotropic effects. 
Participants were then asked to rest in a lounge environment and their resting heart 
rate was obtained over a period of 30 minutes. Following this, participants were then 
taken into a room and took part in 2 hours of cognitive testing. The initial 30 minutes 
of this period was taken as the stressed heart rate. Resting and stressed heart rates and 
measures of autonomic function were obtained after entering the beat-to-beat RR 
interval data obtained by the Actiheart into Kubios HRV, an advanced and easy to use 
software for heart rate variability (HRV) analysis (Tarvainen et al., 2014). The 
following measures were obtained: the root mean squared of successive differences 
(RMSSD), which is a measure of vagal control of the heart (DeGiorgio et al., 2010); 
the low frequency (LF), which corresponds to the 0.10Hz slow fluctuations of arterial 
pressure and reflects sympathetic and parasympathetic tone; the high frequency (HF) 
which corresponds to ~0.25 Hz fluctuations and is a measure of respiratory sinus 
arrhythmias and can be considered an index of vagal modulation; and the LF/HF ratio 
which is used to indicate balance between sympathetic and parasympathetic tone.  
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Long term actiheart recordings 
Following the short term analyses, participants were fitted with the Actiheart in long 
term mode and asked to wear this at home for 7 days to provide continuous heart rate 
and activity monitoring. The participants wore the device continuously and were 
allowed to shower with the device. Carers were given instructions to refit the device if 
it became loose or was removed. From the long-term recording, sleeping heart rate 
and activity counts were calculated. 
 
Measurement of sleeping heart rate 
Sleeping heart rate was calculated over a period of 1 night. For each participant, the 1 
night was selected from the 7 day long term recording where a period of recording of 
uninterrupted sleep was obtained, between midnight and 5 am where no activity was 
detected. From this period, the average sleeping heart rate, minimum and maximum 
heart rate was calculated for each participant. Investigators were blinded to the patient 
ID and diagnoses for this selection. .  
 
Measurement of activity over 24 hours 
An average activity count over 24 hours was calculated for each participant. This was 
obtained by selecting a 24-hour period in the 7 day long-term recording where 
continuous recording was available for each patient. This was found to be day 2 in 
each patient as the Actiheart had been firmly attached and had not been removed, 
which tended to occur as the long term recording proceeded. The average activity 
counts for each patient over these 24 hours was obtained and expressed as an activity 
count per 24 hours. Significance levels between group means were examined after 
correcting for age and sex. 
 
Measurement of energy expenditure 
The Actiheart measures heart rate and activity simultaneously and these data are 
transferred to the Actiheart software which uses a validated branched model equation 
(Brage et al., 2004; Brage et al., 2005) to derive active energy expenditure for each 
epoch using a combination of heart rate and activity. Using the branched model 
equation, group Cal JAP2007 (CamNtech, Cambridge, UK) measures of daily energy 
expenditure were calculated for each participant each day for 7 days and an average 
over this period obtained. The following measures were obtained: Active Energy 
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expenditure (AEE) derived from the branched model equation, which includes a 
combination of heart rate and activity measures; Resting energy expenditure (REE) 
derived from the Schofield equation, designed to measure basal metabolic rate 
adjusted for weight (Schofield, 1985); Dietary induced thermogenesis (DIT), 
estimated as 10% of total energy expenditure; Total energy expenditure (TEE) = 
REE+ AEE+ DIT; Physical activity level (PAL) = TEE/REE. 
 
Behavioural measurements  
In addition to measurements of heart rate variability, activity and energy expenditure, 
changes in eating behaviour were measured using caregiver-based questionnaires: the 
Appetite and Eating Habits Questionnaire (APEHQ) (Ikeda et al., 2002; Ahmed et al., 
2014a) and the Cambridge Behavioural Inventory (CBI) (Bozeat et al., 2000). These 
surveys were completed on the same day the short term recordings were obtained and 
were felt to be representative of intake over the proceeding 7 days when the long term 
recordings were obtained. The APEHQ provides measures of nicotine and alcohol 
consumption. Height and weight were measured barefoot and body mass index (BMI) 
calculated (weight in kilograms/height in metres squared). 
 
Imaging 
 
MRI acquisition and preprocessing 
All participants underwent whole brain structural MRI with a 3 T Phillips scanner 
using a standard 8-channel head coil. 3D high-resolution turbo field echo T1-
weighted sequences were acquired with the following parameters: coronal orientation, 
matrix 256 × 256, 200 slices, 1 mm2 in-plane resolution, slice thickness 1 mm, echo 
time/repetition time 2.6/5.8 ms, flip angle α=8°. MRI scans were obtained on the 
same day as the physiological and behavioural assessment. 
 
Before analyses, the two T1 volumes were merged and averaged to increase the signal 
to noise ratio and the grey matter-white matter contrasts in brain structures. 
FreeSurfer software, version 5.3.0 (http://surfer.nmr.mgh.harvard.edu) was used for 
surface-based cortical processing (Dale et al., 1999; Fischl et al., 1999) using standard 
methods (Fischl and Dale, 2000). Cortical thickness was smoothed with a 20 mm full-
width at half-height Gaussian kernel. This level of blurring kernel was chosen to 
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reduce the impact of imperfect alignment between cortices and thereby improve the 
signal-to-noise ratio (Lerch and Evans, 2005).  
 
In addition, the following subcortical structures were automatically segmented and 
extracted for both hemispheres: thalamus, caudate, putamen, globus pallidus, 
hippocampus, amygdala, and nucleus accumbens. For these subcortical structures, 
measurements from both hemispheres were averaged and adjusted for total 
intracranial volume, in line with previous methodology (Voevodskaya et al., 2014).  
 
All the resulting images were visually inspected and manually corrected in the event 
of tissue segmentation errors. One bvFTD patient and 2 healthy controls were 
excluded due to excessive surface or subcortical segmentation errors. Thus, 18 
bvFTD, 13 AD and 14 healthy controls were included in the imaging analyses. 
 
Statistical analyses 
 
Demographic and physiological variables 
Analyses were conducted using IBM SPSS statistics (version 21.0). Kolmogorov-
Smirnov tests were run to determine suitability of variables for parametric analyses. 
One-way analyses of variance (ANOVA), followed by Tukey post hoc tests, were 
used to determine group differences in demographic and clinical variables (age, ACE-
R). Categorical variables were analyzed using chi-square analyses. Independent t-tests 
were used to determine differences between bvFTD and AD for disease duration, 
abnormal behaviour (total CBI, CBI behavioural) and eating behaviour (APEHQ, CBI 
eating, and BMI) (p ≤ 0.05 regarded as significant). Measurements of heart rate 
(resting and stressed), autonomic function (resting and stressed LF, HF, RMSSD after 
log transformation), activity counts and energy measures (REE, AEE, DIT, PAL) 
were also explored using ANOVA, followed by Tukey post hoc tests. The 
relationship between resting heart rate and disease duration, BMI, eating behaviour 
(APEHQ total score) cognitive status (ACE-III) and behavioural measures (CBI total, 
eating and behavioural) were further explored using Pearson rank correlations 
corrected for multiple comparisons (p ≤ 0.01 regarded as significant). 
 
Imaging data analyses 
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For cortical thickness, sets of vertex-by-vertex analyses were performed using general 
linear models aimed to examine differences in cortical thickness between groups and 
then to estimate the neural correlates for the physiological variables where bvFTD 
showed significant differences with both AD and healthy controls (resting heart rate 
and stressed heart rare). In the first set of analyses, overall cortical thickness of both 
hemispheres was modelled including cortical thickness as a dependent variable and 
group (bvFTD, AD, healthy controls) as an independent variable. In the second set of 
analyses, we created separate linear models, one for each physiological variable under 
examination. Each model included the following repressors: group (bvFTD, AD, 
healthy controls), the physiological variable (resting heart rate, stressed heart rare) 
and the interaction between group and the physiological variable. To determine 
physiological associations with cortical thickness specific to diagnostic group, we 
focused on the interaction effect between each diagnosis and each physiological 
variable. Correlations between physiological variables and cortical thickness were 
investigated first by combining all participants (behavioural variant FTD, , 
Alzheimer’s disease, controls) and then in each patient group combined with controls, 
to identify neural correlates of resting and stressed heart rate to each patient group.. 
Since the groups were matched at baseline for age, sex and duration of disease, no 
covariates were included in the models. Statistical significance was set at p = 0.001 
uncorrected for multiple comparisons. In addition, we used a conservative cluster 
extent threshold of k > 50 mm
2
. This approach is designed to minimize Type I error 
while balancing the risk of Type II error (Lieberman and Cunningham, 2009). 
For the subcortical regions, group comparisons of subcortical volumes between 
bvFTD, AD and healthy controls were performed using ANOVA. Post hoc analyses 
were corrected for multiple comparisons using a Sidak adjustment. Next, in order to 
uncover the subcortical grey matter correlates of resting heart rate and stressed heart 
rate, correlations were investigated using the same approach outlined above. Pearson 
two-tailed correlational analyses were conducted with Bonferroni correction for 
multiple comparisons (p < ∝/ = .007).  
 
Region of interest analyses 
In addition to the whole-brain analyses, a set of cortical regions of interest (ROI) were 
selected and computed and averaged from the regional parcellations provided by 
FreeSurfer for both hemispheres. These regions were selected according to previous 
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findings in the literature examining associations between autonomic function (e.g., 
pain and temperature and heart rate) and brain regions in bvFTD and AD and normal 
controls (Critchley et al., 2003; Jones, 2011; Fletcher et al., 2015a). The regions 
selected included the prefrontal, mesial temporal and anterior cingulate cortices, and 
the insula. Details on the computation of these measurements can be found in 
Supplementary Table S1. Pearson two-tailed correlations were used to examine 
associations between these ROIs and the resting and stressed heart rate. These 
analyses were Bonferroni corrected to control for multiple comparisons (p < ∝/ = 
.0125).  
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Results 
 
Participants groups were representative of the diseases studied and did not differ in 
sex distribution, age or disease duration (Table 1, all p values > 0.365). Group 
differences were observed on measures of cognition (ACE-III), behavioural measures 
and eating behaviour (Table 1) and were in keeping with the known behaviour of the 
diagnostic groups. On the ACE-III as expected the patient groups scored lower than 
controls (p < .001). The bvFTD group was more functionally impaired relative to AD 
(FRS; t = 3.3, p = .03). The bvFTD group as expected scored higher than the AD 
group on the total CBI score (t = 3.6, p = .001), and CBI behavioural score (t = 4.1, p 
< .001).  
 
Medications, smoking and alcohol intake (Table 1) 
As expected, a higher number of AD patients were on cholinesterase inhibitors (9 
patients) compared to the bvFTD (2 patients) and control (no patient) groups. There 
was no difference in the number of patients treated with a medication likely to affect 
heart rate and cardiac conduction (e.g. beta blocker, calcium channel blocker) 
between the groups. One bvFTD patient was on stable and adequate thyroxine 
treatment. Two bvFTD patients and 2 control subjects were current smokers. Eight 
bvFTD patients carers reported that they consumed alcohol normally, less than 
weekly in 4 and several times per week in 4. Ten control subjects reported alcohol 
consumption, 4 less than weekly and 6 several times a week. Five AD patients 
reported alcohol intake regularly, 2 several times a week and 3 less than weekly. No 
patient or control participant stated that they consumed more alcohol than the 
recommended amount by the Australian National Health and Medical research 
council. 
 
Eating behaviour and BMI 
On both the APEHQ and CBI eating score the bvFTD group showed more severe 
eating disturbance based on caregiver surveys compared with AD (t = 4.1, p < .001). 
The bvFTD group had an increased BMI (Figure 1) compared to the AD (p = .001) 
and Control groups (p = .008) (Table 1).   
[INSERT FIGURE 1 HERE] 
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Heart rate and autonomic function 
Significant group differences were present for both resting (F= 8.6, p = .001) and 
stressed (F= 3.2, p = .047) heart rate measures. The bvFTD group (mean = 81.8 bpm 
had an increased resting heart rate compared to both the control (mean= 68.5 p = 
.001) and AD groups (mean = 72.5, p = .020) and an increased stressed heart rate 
compared to the control group (bvFTD = 81.5, AD= 76.1, Control= 71.9; p = .037) 
(Figure 2). On measures of autonomic function (Table 2), no significant group 
differences were detected; however, a trend for the bvFTD group to have a decreased 
RMSSD value, in both resting (p = .076) and stressed states (p = .063) was present 
 
[INSERT FIGURE 2 HERE] 
 
Correlations of resting heart rate with behavioural measures 
When all groups were combined, resting heart rate was positively correlated with 
behavioural and eating changes as r flected by the CBI total (r  = .417, p = .004), CBI 
behavioural (r  = .451, p = .001), and total CBI eating score (r  = .307, p = .01), and 
negatively correlated with cognitive function on the ACE-III (r = -.314, p = .01), 
functional ability on the FRS (r  = -.308, p =.05). As in prior studies, an increased 
BMI correlated with behavioural changes on the CBI total (r  = .369, p = .01), CBI 
behavioural (r  = .334, p = .01), and total CBI eating score (r  = .397, p = .006), and 
the APEHQ (r  = .461, p = .01). BMI did not correlate with resting heart rate (r  = 
.206, p = .160). 
 
Long term actiheart recordings 
Long-term recordings over 7 days were obtained for 12 bvFTD, 10 AD, and 11 
control participants to measure sleeping heart rate and activity levels. Several bvFTD 
patients refused to wear the Actiheart or when at home disposed of it. The patients in 
the subset analyses did not differ from the larger group in which short term recordings 
and imaging correlation were conducted. 
 
Sleeping heart rate 
As with resting and stressed heart rate significant group differences were also 
detected in mean sleeping heart rate (Figure 3a) (F = 3.9, p = .032) with the bvFTD 
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group (mean= 71.6 bpm) having an increased sleeping heart rate compared to the 
control group (mean= 61.5 p = .038) and a trend compared to the AD group (mean = 
62.8 p = .085).  No group differences (F = 1.4 p = .270) in mean minimum heart rate 
were detected between the bvFTD (58.9 ± 7.3 bpm), AD (54.7 ± 8.2) and control 
groups (55.1 ± 5.2). By contrast, the bvFTD group (100.2 ± 13.9) had an increased 
maximum heart rate compared to the control group (95.7 ± 14.3 bpm; F= 4.2 p= 
.025). 
 
Activity levels 
Group differences were detected on activity counts (Figure 3b) over a 24 hour period, 
after correcting for age and sex. Contrary to what was expected both the bvFTD (p = 
.002) and AD groups (p= .05) showed significantly decreased activity counts per hour 
compared with the controls, suggesting particularly that the bvFTD group has reduced 
activity levels. 
 
[INSERT FIGURE 3 HERE] 
 
Energy expenditure 
On examination of energy expenditure group differences were present (Table 3), with 
the bvFTD group having an increased resting energy expenditure compared to the 
control (p= .045) and AD (p= .005) groups. The bvFTD group also had an increased 
diet induced thermogenesis and total energy expenditure compared to the other 
groups. Despite the finding of decreased activity counts in bvFTD, no significant 
group differences in active energy expenditure were observed (calculated as a 
combination of heart rate and activity levels), suggesting that the decreased activity 
counts in bvFTD may not have affected the active energy expenditure, due to the 
increased heart rate seen in this group. 
 
Imaging analyses 
 
Atrophy analyses 
Group comparisons between each clinical group and controls revealed the 
characteristic profiles of brain atrophy previously reported as consistent with a 
diagnoses of bvFTD and AD. These results are presented in Supplementary Figure S1 
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and Supplementary Table S2. In brief, bvFTD patients showed atrophy in the insula 
and inferior frontal and anterior temporal cortices. In contrast, AD patients 
demonstrated widespread and bilateral atrophy involving parietal, temporal and to a 
lesser extent frontal regions, compared with controls. In addition, both clinical groups 
showed atrophy in all subcortical structures measured compared with controls, with 
the exception of the thalamus and the globus pallidus (Supplementary Table S2). The 
amount of atrophy in these structures was of similar magnitude in bvFTD and AD.  
 
Neural correlates of resting and stressed heart rate 
Unbiased whole brain analyses yielded a significant association between increasing 
resting heart rate and cortical thinning in the right posterior cingulate and right 
inferior parietal cortex when combining  bvFTD and AD patients together (Figure 4).  
 
[INSERT FIGURE 4 HERE] 
 
In bvFTD but not in AD, increased resting heart rate was associated with volume 
reductions in the thalamus (r = -.349, p = .05), caudate (r = -.334, p = .06), putamen (r 
= -.342, p = .05), hippocampus (r = -.529, p = .002), amygdala (r = -.353, p = .04) and 
nucleus accumbens (r = -.446, p = .01), structures which are known in normal 
controls to be involved in autonomic regulation. Of these correlations, only the 
association between reduced hippocampal volume and increased resting heart rate 
survived conservative Bonferroni correction for multiple comparisons (Table 4).  
 
[INSERT TABLE 4 HERE] 
 
Also in bvFTD but not in AD, ROI analyses uncovered significant associations 
between increased resting heart rate and cortical thinning in the mesial temporal 
cortex (r = -.520, p = .002) and the insula (r = -.490, p = .004). Additional correlations 
were also found with the prefrontal (r = -.359, p = .04) and anterior cingulate cortices 
(r =-.352, p = .04), again structures known to be integral to autonomic control, 
although these did not survive correction for multiple comparisons (Figure 5). 
 
[INSERT FIGURE 5 HERE] 
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No further significant associations were found between stressed heart rate and cortical 
or subcortical regions in either bvFTD or AD. 
 
Discussion 
 
Behavioural variant frontotemporal dementia is characterized by an increased resting, 
stressed and sleeping heart rate compared to both AD and healthy controls. Given that 
changes in heart rate are indicative of changes in metabolic rate and energy 
expenditure (Berggren and Hohwu Christensen, 1950; Penzel et al., 2003), via the 
relationship between pulse rate, circulation and oxygen consumption, these changes 
suggest the presence of a hypermetabolic state in bvFTD. Behavioural variant 
frontotemporal dementia is also characterised by increased resting energy 
expenditure, total energy expenditure and decreased activity levels.. Changes in heart 
rate correlate to a neural network involving the mesial temporal cortex, insula, 
nucleaus accumbens and cingulate.  
 
In ALS, which overlaps clinically, pathologically and genetically with bvFTD, 
changes in heart rate (Chida et al., 1989)  and a state of hypermetabolism (Desport et 
al., 2001) have also been documented, with an increased heart rate on formal 
autonomic function testing being found secondary to increased sympathetic and 
decreased parasympathetic input (Chida et al., 1989). In the present study, indications 
of decreased vagal tone and parasympathetic input in bvFTD were also present, with a 
trend towards decreased RMSSD, which is a measure of heart rate variability and 
reflects the integrity of vagus nerve mediated control of the heart (DeGiorgio et al., 
2010). There is good experimental evidence in rodents and humans that changes in 
autonomic tone induced directly or indirectly (for example through thyroid disorders) 
affect energy expenditure and peripheral metabolism (lipolysis) (Nonogaki, 2000; 
Penicaud et al., 2000; Messina et al., 2013). It is therefore readily plausible that 
changes in heart rate may alter energy expenditure in patients with FTD. However, 
this remains to be established in studies using indirect calorimetry although we note 
these can be quite challenging in patients with complex behavioural problems.  
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Anecdotally, patients with bvFTD are described as being restless with pacing 
behaviour or alternatively to show inertia (Piguet et al., 2009), but activity levels have 
not been systematically examined. It has also been suggested that bvFTD patients 
may not show the degree of weight gain expected in the setting of their increased 
eating due to hyperactivity (Woolley et al., 2007). Here, however, we have 
demonstrated that bvFTD patients show decreased activity levels compared with 
healthy controls. This decreased activity may be secondary to the increased apathy 
seen in this disorder, which has been, related to atrophy in the right caudate, ventral 
striatum and cortical basal ganglia circuits (Eslinger et al., 2012), brain regions 
commonly affected in bvFTD. 
 
In addition, bvFTD patients exhibited an increased resting energy expenditure (REE), 
a measure of the resting metabolic rate, and  total energy expenditure. The increased 
REE and basal metabolic state may in part be explained by the increased body mass 
index seen in the bvFTD group, but may also be influenced by the presence of a 
hypermetabolic state. This finding is in keeping with results in ALS showing that 
ALS patients may show total energy expenditure well above their REE and activity 
levels and potentially secondary to hypermetabolism (Kasarskis et al., 2014). 
 
Increased resting heart rate was also found to correlate with increasing cognitive 
impairment (lower ACE-III scores) and increasing behavioural impairment (higher 
CBI scores). Changes in neurodegeneration have been linked to alterations in energy 
homeostasis with animal models of ALS and FTD associated with weight loss and 
hypermetabolism (Dupuis et al., 2004; Chiang et al., 2010; Shan et al., 2010; Xu et 
al., 2010). Additional studies in patients with the language variants of FTD, 
particularly Semantic dementia may be informative. It is suspected that there may 
well be changes in energy expenditure in semantic dementia given that they have 
similar changes in BMI to bvFTD in the contenxt of eating behavioural changes 
(Ahmed et al 2014) and a similar pathology to ALS (TDP-43), where energy changes 
are prominent (Dupuis et al., 2011; Ahmed et al., 2016b). 
 
It may be suggested that the changes seen in heart rate in bvFTD i.e. an increased 
resting and stressed and sleeping heart may be secondary to environmental factors 
such as caffeine, nicotine or alcohol consumption. This seems unlikely given that 
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there was no difference in reported smoking frequency and alcohol consumption 
between the groups, with only 2 bvFTD and 2 control subjects reported to be 
smokers, and similar rates of reported regular alcohol consumption, which were 
within recommended national guidelines.  It is also unlikely that caffeine and tea 
intake would have affected the short term heart rate recordings (resting and stressed 
heart rate) as patients attended fasted and then received a breakfast with no caffeine 
available. Caffeine and tea intake was not measured during the long term 
measurements and this could potentially confound the long term recordings, however 
this is unlikely given that resting heart was elevated in the setting of the controlled 
environment of no caffeine consumption for the short term recordings. .When 
considering these results, it should be noted that changes in heart rate may potentially 
be related to decreased physical fitness associated with increasing disease severity, 
decreased activity secondary to apathy or loss of independence. However as increases 
in heart rate did not correlate with BMI changes, this suggests that changes in heart 
rate are far more complex than just being related to physical fitness and likely 
represent a complex interaction between atrophy in key cortical areas affecting 
autonomic function, and energy expenditure, and are likely to be centrally rather than 
peripherally mediated.  
 
Whilst medications that potentially affect heart rate may affect the results of our 
study, there was no significant difference in use of chronotropic drugs between the 
groups. Cholinesterase inhibitor treatment has been linked with bradycardia in a small 
proportion of patients (Hernandez et al., 2009). Despite the high number of AD 
patients on this medication, this is unlikely to be a confounding issue in the current 
study as the mean resting heart rate in the AD group was above that seen in the 
normal control population.  
 
In this study, an increased resting heart rate in bvFTD was found to correlate with 
atrophy of the mesial temporal cortex including hippocampus, together with the 
amygdala, nucleus accumbens, insula and cingulate, all structures known to be 
integral to autonomic control of the human body and involving the limbic system, 
which is known to be involved in FTD (Seeley et al., 2008; Jones, 2011). In bvFTD, 
pathological changes in these structures have traditionally being linked to disturbance 
of memory and social cognition (Galton et al., 2001; Kipps et al., 2009; Kumfor et al., 
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2013; Irish et al., 2014). Recently decreased cardiac vagal tone has been found in 
bvFTD and linked to reduced agreeableness and a network involving left-lateralized 
functional and structural frontoinsular and cingulate cortex deficits (Guo et al., 2016). 
Our findings suggest that in addition these structures may have a fundamental role in 
autonomic, energy expenditure and metabolic control in bvFTD. 
 
The anterior cingulate cortex, has been shown to participate in decision making, 
response selection (Devinsky et al., 1995), anticipation of reward, task reinforcement 
(Amiez et al., 2006; Rushworth et al., 2007) and in controlling visceromotor, 
endocrine and skeletomotor outputs (Vogt et al., 1992), potentially via integration of 
cognitive with autonomic information (Critchley et al., 2001). In healthy individuals, 
activity of the anterior cingulate cortex has been associated with increased body mass 
index (Volkow et al., 2009) suggesting a role for this structure in regulating eating 
and metabolism. It has also been shown that the anterior cingulate cortex is related to 
sympathetic modulation of heart rate dissociable from cognitive and motor related 
activity and that focal damage to brain region can result in both an increase and 
decrease in heart rate (Critchley et al., 2003). Although the cingulate cortex responds 
to emotional stimuli, it is also metabolically active at rest (Raichle et al., 2001; Luu 
and Posner, 2003), suggesting a pivotal role for this brain region in the normal 
physiological control of the body. 
 
Several studies and meta-analyses have shown the integral role that the amygdala 
plays in controlling heart and heart rate variability, particularly in times of emotional 
response and threat (Thayer et al., 2012). The fact that the amygdala correlated with 
increased resting heart rate in bvFTD in the current study, suggests that this structure 
plays a role in the physiological and metabolic changes seen in bvFTD and not simply 
in response to emotional stimuli. The insula is involved early in the course of bvFTD 
(Seeley et al., 2008) and has been found on voxel-based morphometry (VBM) to 
correlate to pain and temperature symptoms in bvFTD, with the suggestion that it 
forms a network hub for sensory homeostatic signalling with the thalamus in bvFTD. 
(Fletcher et al., 2015a). Our findings suggest that the insula also forms an important 
part of the network involved in heart rate, energy expenditure, autonomic and 
metabolic control in bvFTD. 
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It is of interest that several of the structures found to correlate with increased resting 
heart rate namely the cingulate cortex, insula and amygdala have been found to 
correlate with hyperphagia and abnormal eating behaviour in bvFTD. Moreover all of 
these structures have connections to the hypothalamus (Kullmann et al., 2014; Ahmed 
et al., 2016a), which has been found to be atrophied in bvFTD and correlate with BMI 
measures (Ahmed et al., 2015b). This suggests a complex interaction between 
cortical, subcortical structures and the hypothalamus in the control of eating 
behaviour, heart rate and energy expenditure all of which are affected in bvFTD. 
 
In AD, by contrast, it has been speculated that weight loss occurs with disease 
progression and low body weight has previously being correlated to mesial temporal 
cortex atrophy (Grundman et al., 1996). Further studies using direct measurements of 
energy intake and expenditure in large numbers of patients and age-and BMI-matched 
controls (both normal and AD patients) longitudinally are required to assess the 
relative contributions of these parameters to weight changes in FTD.   
 
Behavioural variant frontotemporal dementia is characterized by an increased resting 
and sleeping heart rate indicative of changes in metabolic rate and resting energy 
expenditure which may moderate the weight gain in the setting of prominent changes 
of eating behaviour. BvFTD is also accompanied by decreased activity levels 
suggesting that energy expenditure changes are likely secondary to intrinsic 
processes, driven by changes in heart rate, rather than by an increase in activity levels. 
Changes in heart rate correlated with atrophy of cingulate and limbic systems 
including the insula and amygdala, which overlap with networks known to control 
eating behaviour in bvFTD. Further studies are required to document changes in heart 
rate and energy expenditure across the ALS-FTD spectrum and in presymptomatic 
genetic cohorts, to ascertain when changes first develop during the course of the 
disease.  An approach combining longitudinal clinical studies and animal models of 
FTD and ALS will prove crucial. The current study is the first study to measure the 
interaction between heart rate, autonomic function and energy expenditure in FTD, 
using methods from obesity research that allow for measurements over both short 
term and long term (7 days) in the patient’s normal environment. Further studies 
using indirect calorimetry to measure basal metabolic rate and total energy 
expenditure are warranted to further examine these interactions. An understanding of 
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the potential changes in energy expenditure, autonomic function and their neural 
correlates including involvement of the mesial temporal cortex, cingulate cortex, 
amygdala and insula in energy expenditure aids in the physiological phenotyping of 
FTD and extends our knowledge of the disease beyond cognition and emotion 
processing.  
 
 
Funding: This work was supported by funding to Forefront, a collaborative research 
group dedicated to the study of frontotemporal dementia and motor neurone disease, 
from the National Health and Medical Research Council of Australia (NHMRC) 
program grant (#1037746 to MK and JH) and the Australian Research Council Centre 
of Excellence in Cognition and its Disorders Memory Node (#CE110001021 to OP 
and JH) and other grants/sources (NHMRC project grant #1003139). We are grateful 
to the research participants involved with the ForeFront research studies. RA is a 
Royal Australasian College of Physicians PhD scholar and MND Australia PhD 
scholar. OP is an NHMRC Career Development Research Fellow (#1022684). ISF is 
supported by the Wellcome Trust, Medical Research Council, European Research 
Council, NIHR Cambridge Biomedical Research Centre and The Bernard Wolfe 
Endowment. AAvdK is supported by the Wellcome Trust. THC is supported by 
research grants from the Swiss National Science Foundation (PBLAP3-145870, 
P3SMP3-155318). 
 
Author disclosures: The authors declare no competing financial interests 
 
Author contributions: 
Rebekah Ahmed: study concept, data analyses, manuscript preparation and writing.
 
Ramon Landin-Romero: data analyses, manuscript preparation and writing. 
Tinh-Hai Collet: data analyses, manuscript preparation and writing. 
Agatha van der Klaauw: data analyses, manuscript preparation and writing 
Emma Devenney: data analyses, manuscript preparation and writing
 
Elana Henning: data analyses, manuscript preparation and writing. 
Matthew C Kiernan: data analyses, manuscript preparation and writing. 
Olivier Piguet: data analyses, manuscript preparation and writing. 
Sadaf Farooqi: study concept, data analyses, manuscript preparation and writing. 
John Hodges: study concept, data analyses, manuscript preparation and writing. 
 
 
  
Page 21 of 76
ScholarOne, 375 Greenbrier Drive, Charlottesville, VA, 22901  Support (434) 964 4100
Brain
For Peer Review
 22
References 
Ahmed RM, Irish M, Kam J, van Keizerswaard J, Bartley L, Samaras K, Hodges JR, 
Piguet O. Quantifying the eating abnormalities in frontotemporal 
dementia. JAMA Neurol 2014a; 71: 1540-6. 
Ahmed RM, MacMillan M, Bartley L, Halliday GM, Kiernan MC, Hodges JR, Piguet 
O. Systemic metabolism in frontotemporal dementia. Neurology 2014b; 
83: 1812-8. 
Ahmed RM, Iodice V, Daveson N, Kiernan MC, Piguet O, Hodges JR. Autonomic 
dysregulation in frontotemporal dementia. J Neurol Neurosurg Psychiatry 
2015a; 86: 1048-9. 
Ahmed RM, Latheef S, Bartley L, Irish M, Halliday GM, Kiernan MC, Hodges JR, 
Piguet O. Eating behavior in frontotemporal dementia: Peripheral 
hormones vs hypothalamic pathology. Neurology 2015b; 85: 1310-7. 
Ahmed RM, Irish M, Henning E, Dermody N, Bartley L, Kiernan MC, Piguet O, 
Farooqi S, Hodges JR. Assessment of Eating Behavior Disturbance and 
Associated Neural Networks in Frontotemporal Dementia. JAMA Neurol 
2016a; 73: 282-90. 
Ahmed RM, Irish M, Piguet O, Halliday GM, Ittner LM, Farooqi S, Hodges JR, 
Kiernan MC. Amyotrophic lateral sclerosis and frontotemporal dementia: 
distinct and overlapping changes in eating behaviour and metabolism. 
Lancet Neurol 2016b; 15: 332-42. 
Amiez C, Joseph JP, Procyk E. Reward encoding in the monkey anterior cingulate 
cortex. Cereb Cortex 2006; 16: 1040-55. 
Berggren G, Hohwu Christensen E. Heart rate and body temperature as indices of 
metabolic rate during work. Arbeitsphysiologie 1950; 14: 255-60. 
Bouteloup C, Desport JC, Clavelou P, Guy N, Derumeaux-Burel H, Ferrier A, 
Couratier P. Hypermetabolism in ALS patients: an early and persistent 
phenomenon. J Neurol 2009; 256: 1236-42. 
Bozeat S, Gregory CA, Ralph MA, Hodges JR. Which neuropsychiatric and 
behavioural features distinguish frontal and temporal variants of 
frontotemporal dementia from Alzheimer's disease? J Neurol Neurosurg 
Psychiatry 2000; 69: 178-86. 
Brage S, Brage N, Franks PW, Ekelund U, Wong MY, Andersen LB, Froberg K, 
Wareham NJ. Branched equation modeling of simultaneous accelerometry 
and heart rate monitoring improves estimate of directly measured 
physical activity energy expenditure. J Appl Physiol (1985) 2004; 96: 343-
51. 
Brage S, Brage N, Franks PW, Ekelund U, Wareham NJ. Reliability and validity of 
the combined heart rate and movement sensor Actiheart. Eur J Clin Nutr 
2005; 59: 561-70. 
Chiang PM, Ling J, Jeong YH, Price DL, Aja SM, Wong PC. Deletion of TDP-43 
down-regulates Tbc1d1, a gene linked to obesity, and alters body fat 
metabolism. Proc Natl Acad Sci U S A 2010; 107: 16320-4. 
Chida K, Sakamaki S, Takasu T. Alteration in autonomic function and 
cardiovascular regulation in amyotrophic lateral sclerosis. J Neurol 1989; 
236: 127-30. 
Critchley HD, Mathias CJ, Dolan RJ. Neural activity in the human brain relating to 
uncertainty and arousal during anticipation. Neuron 2001; 29: 537-45. 
Page 22 of 76
ScholarOne, 375 Greenbrier Drive, Charlottesville, VA, 22901  Support (434) 964 4100
Brain
For Peer Review
 23
Critchley HD, Mathias CJ, Josephs O, O'Doherty J, Zanini S, Dewar BK, Cipolotti L, 
Shallice T, Dolan RJ. Human cingulate cortex and autonomic control: 
converging neuroimaging and clinical evidence. Brain 2003; 126: 2139-
52. 
Crouter SE, Churilla JR, Bassett DR, Jr. Accuracy of the Actiheart for the 
assessment of energy expenditure in adults. Eur J Clin Nutr 2008; 62: 704-
11. 
Dale AM, Fischl B, Sereno MI. Cortical surface-based analysis. I. Segmentation and 
surface reconstruction. Neuroimage 1999; 9: 179-94. 
DeGiorgio CM, Miller P, Meymandi S, Chin A, Epps J, Gordon S, Gornbein J, Harper 
RM. RMSSD, a measure of vagus-mediated heart rate variability, is 
associated with risk factors for SUDEP: the SUDEP-7 Inventory. Epilepsy 
Behav 2010; 19: 78-81. 
Desport JC, Preux PM, Magy L, Boirie Y, Vallat JM, Beaufrere B, Couratier P. 
Factors correlated with hypermetabolism in patients with amyotrophic 
lateral sclerosis. Am J Clin Nutr 2001; 74: 328-34. 
Devinsky O, Morrell MJ, Vogt BA. Contributions of anterior cingulate cortex to 
behaviour. Brain 1995; 118 ( Pt 1): 279-306. 
Dupuis L, Oudart H, Rene F, Gonzalez de Aguilar JL, Loeffler JP. Evidence for 
defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a 
high-energy diet in a transgenic mouse model. Proc Natl Acad Sci U S A 
2004; 101: 11159-64. 
Dupuis L, Pradat PF, Ludolph AC, Loeffler JP. Energy metabolism in amyotrophic 
lateral sclerosis. Lancet Neurol 2011; 10: 75-82. 
Eslinger PJ, Moore P, Antani S, Anderson C, Grossman M. Apathy in 
frontotemporal dementia: behavioral and neuroimaging correlates. Behav 
Neurol 2012; 25: 127-36. 
Fischl B, Sereno MI, Dale AM. Cortical surface-based analysis. II: Inflation, 
flattening, and a surface-based coordinate system. Neuroimage 1999; 9: 
195-207. 
Fischl B, Dale AM. Measuring the thickness of the human cerebral cortex from 
magnetic resonance images. Proc Natl Acad Sci U S A 2000; 97: 11050-5. 
Fletcher PD, Downey LE, Golden HL, Clark CN, Slattery CF, Paterson RW, Rohrer 
JD, Schott JM, Rossor MN, Warren JD. Pain and temperature processing in 
dementia: a clinical and neuroanatomical analysis. Brain 2015a; 138: 
3360-72. 
Fletcher PD, Nicholas JM, Shakespeare TJ, Downey LE, Golden HL, Agustus JL, 
Clark CN, Mummery CJ, Schott JM, Crutch SJ, Warren JD. Physiological 
phenotyping of dementias using emotional sounds. Alzheimers Dement 
(Amst) 2015b; 1: 170-178. 
Galton CJ, Gomez-Anson B, Antoun N, Scheltens P, Patterson K, Graves M, 
Sahakian BJ, Hodges JR. Temporal lobe rating scale: application to 
Alzheimer's disease and frontotemporal dementia. J Neurol Neurosurg 
Psychiatry 2001; 70: 165-73. 
Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, Cappa SF, Ogar 
JM, Rohrer JD, Black S, Boeve BF, Manes F, Dronkers NF, Vandenberghe R, 
Rascovsky K, Patterson K, Miller BL, Knopman DS, Hodges JR, Mesulam 
MM, Grossman M. Classification of primary progressive aphasia and its 
variants. Neurology 2011; 76: 1006-14. 
Page 23 of 76
ScholarOne, 375 Greenbrier Drive, Charlottesville, VA, 22901  Support (434) 964 4100
Brain
For Peer Review
 24
Grundman M, Corey-Bloom J, Jernigan T, Archibald S, Thal LJ. Low body weight in 
Alzheimer's disease is associated with mesial temporal cortex atrophy. 
Neurology 1996; 46: 1585-91. 
Guo CC, Sturm VE, Zhou J, Gennatas ED, Trujillo AJ, Hua AY, Crawford R, Stables L, 
Kramer JH, Rankin K, Levenson RW, Rosen HJ, Miller BL, Seeley WW. 
Dominant hemisphere lateralization of cortical parasympathetic control 
as revealed by frontotemporal dementia. Proc Natl Acad Sci U S A 2016. 
Hernandez RK, Farwell W, Cantor MD, Lawler EV. Cholinesterase inhibitors and 
incidence of bradycardia in patients with dementia in the veterans affairs 
new England healthcare system. J Am Geriatr Soc 2009; 57: 1997-2003. 
Hsieh S, Schubert S, Hoon C, Mioshi E, Hodges JR. Validation of the 
Addenbrooke's Cognitive Examination III in frontotemporal dementia and 
Alzheimer's disease. Dement Geriatr Cogn Disord 2013; 36: 242-50. 
Ikeda M, Brown J, Holland AJ, Fukuhara R, Hodges JR. Changes in appetite, food 
preference, and eating habits in frontotemporal dementia and 
Alzheimer's disease. J Neurol Neurosurg Psychiatry 2002; 73: 371-6. 
Irish M, Piguet O, Hodges JR, Hornberger M. Common and unique gray matter 
correlates of episodic memory dysfunction in frontotemporal dementia 
and Alzheimer's disease. Hum Brain Mapp 2014; 35: 1422-35. 
Jones SE. Imaging for autonomic dysfunction. Cleve Clin J Med 2011; 78 Suppl 1: 
S69-74. 
Kasarskis EJ, Mendiondo MS, Matthews DE, Mitsumoto H, Tandan R, Simmons Z, 
Bromberg MB, Kryscio RJ, Group ALSNNS. Estimating daily energy 
expenditure in individuals with amyotrophic lateral sclerosis. Am J Clin 
Nutr 2014; 99: 792-803. 
Kipps CM, Nestor PJ, Acosta-Cabronero J, Arnold R, Hodges JR. Understanding 
social dysfunction in the behavioural variant of frontotemporal dementia: 
the role of emotion and sarcasm processing. Brain 2009; 132: 592-603. 
Koppers M, Blokhuis AM, Westeneng HJ, Terpstra ML, Zundel CA, Vieira de Sa R, 
Schellevis RD, Waite AJ, Blake DJ, Veldink JH, van den Berg LH, 
Pasterkamp RJ. C9orf72 ablation in mice does not cause motor neuron 
degeneration or motor deficits. Ann Neurol 2015; 78: 426-38. 
Kullmann S, Heni M, Linder K, Zipfel S, Haring HU, Veit R, Fritsche A, Preissl H. 
Resting-state functional connectivity of the human hypothalamus. Hum 
Brain Mapp 2014; 35: 6088-96. 
Kumfor F, Irish M, Hodges JR, Piguet O. Discrete Neural Correlates for the 
Recognition of Negative Emotions: Insights from Frontotemporal 
Dementia. PLoS One 2013; 8: e67457. 
Lerch JP, Evans AC. Cortical thickness analysis examined through power analysis 
and a population simulation. Neuroimage 2005; 24: 163-73. 
Lieberman MD, Cunningham WA. Type I and Type II error concerns in fMRI 
research: re-balancing the scale. Soc Cogn Affect Neurosci 2009; 4: 423-8. 
Luu P, Posner MI. Anterior cingulate cortex regulation of sympathetic activity. 
Brain 2003; 126: 2119-20. 
McKhann GM, Albert MS, Grossman M, Miller B, Dickson D, Trojanowski JQ, Work 
Group on Frontotemporal D, Pick's D. Clinical and pathological diagnosis 
of frontotemporal dementia: report of the Work Group on 
Frontotemporal Dementia and Pick's Disease. Arch Neurol 2001; 58: 
1803-9. 
Page 24 of 76
ScholarOne, 375 Greenbrier Drive, Charlottesville, VA, 22901  Support (434) 964 4100
Brain
For Peer Review
 25
McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR, Jr., Kawas CH, 
Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor 
MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH. The 
diagnosis of dementia due to Alzheimer's disease: recommendations from 
the National Institute on Aging-Alzheimer's Association workgroups on 
diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011; 
7: 263-9. 
Messina G, De Luca V, Viggiano A, Ascione A, Iannaccone T, Chieffi S, Monda M. 
Autonomic nervous system in the control of energy balance and body 
weight: personal contributions. Neurol Res Int 2013; 2013: 639280. 
Mioshi E, Hsieh S, Savage S, Hornberger M, Hodges JR. Clinical staging and 
disease progression in frontotemporal dementia. Neurology 2010; 74: 
1591-7. 
Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. 
Neurology 1993; 43: 2412-4. 
Nonogaki K. New insights into sympathetic regulation of glucose and fat 
metabolism. Diabetologia 2000; 43: 533-49. 
Pearce LR, Atanassova N, Banton MC, Bottomley B, van der Klaauw AA, Revelli JP, 
Hendricks A, Keogh JM, Henning E, Doree D, Jeter-Jones S, Garg S, 
Bochukova EG, Bounds R, Ashford S, Gayton E, Hindmarsh PC, Shield JP, 
Crowne E, Barford D, Wareham NJ, consortium UK, O'Rahilly S, Murphy 
MP, Powell DR, Barroso I, Farooqi IS. KSR2 mutations are associated with 
obesity, insulin resistance, and impaired cellular fuel oxidation. Cell 2013; 
155: 765-77. 
Penicaud L, Cousin B, Leloup C, Lorsignol A, Casteilla L. The autonomic nervous 
system, adipose tissue plasticity, and energy balance. Nutrition 2000; 16: 
903-8. 
Penzel T, Kantelhardt JW, Lo CC, Voigt K, Vogelmeier C. Dynamics of heart rate 
and sleep stages in normals and patients with sleep apnea. 
Neuropsychopharmacology 2003; 28 Suppl 1: S48-53. 
Piguet O, Hornberger M, Shelley BP, Kipps CM, Hodges JR. Sensitivity of current 
criteria for the diagnosis of behavioral variant frontotemporal dementia. 
Neurology 2009; 72: 732-7. 
Raichle ME, MacLeod AM, Snyder AZ, Powers WJ, Gusnard DA, Shulman GL. A 
default mode of brain function. Proc Natl Acad Sci U S A 2001; 98: 676-82. 
Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J, van 
Swieten JC, Seelaar H, Dopper EG, Onyike CU, Hillis AE, Josephs KA, Boeve 
BF, Kertesz A, Seeley WW, Rankin KP, Johnson JK, Gorno-Tempini ML, 
Rosen H, Prioleau-Latham CE, Lee A, Kipps CM, Lillo P, Piguet O, Rohrer 
JD, Rossor MN, Warren JD, Fox NC, Galasko D, Salmon DP, Black SE, 
Mesulam M, Weintraub S, Dickerson BC, Diehl-Schmid J, Pasquier F, 
Deramecourt V, Lebert F, Pijnenburg Y, Chow TW, Manes F, Grafman J, 
Cappa SF, Freedman M, Grossman M, Miller BL. Sensitivity of revised 
diagnostic criteria for the behavioural variant of frontotemporal 
dementia. Brain 2011; 134: 2456-77. 
Rushworth MF, Behrens TE, Rudebeck PH, Walton ME. Contrasting roles for 
cingulate and orbitofrontal cortex in decisions and social behaviour. 
Trends Cogn Sci 2007; 11: 168-76. 
Page 25 of 76
ScholarOne, 375 Greenbrier Drive, Charlottesville, VA, 22901  Support (434) 964 4100
Brain
For Peer Review
 26
Schofield WN. Predicting basal metabolic rate, new standards and review of 
previous work. Hum Nutr Clin Nutr 1985; 39 Suppl 1: 5-41. 
Seeley WW, Crawford R, Rascovsky K, Kramer JH, Weiner M, Miller BL, Gorno-
Tempini ML. Frontal paralimbic network atrophy in very mild behavioral 
variant frontotemporal dementia. Arch Neurol 2008; 65: 249-55. 
Shan X, Chiang PM, Price DL, Wong PC. Altered distributions of Gemini of coiled 
bodies and mitochondria in motor neurons of TDP-43 transgenic mice. 
Proc Natl Acad Sci U S A 2010; 107: 16325-30. 
Tarvainen MP, Niskanen JP, Lipponen JA, Ranta-Aho PO, Karjalainen PA. Kubios 
HRV--heart rate variability analysis software. Comput Methods Programs 
Biomed 2014; 113: 210-20. 
Thayer JF, Ahs F, Fredrikson M, Sollers JJ, 3rd, Wager TD. A meta-analysis of 
heart rate variability and neuroimaging studies: implications for heart 
rate variability as a marker of stress and health. Neurosci Biobehav Rev 
2012; 36: 747-56. 
Vaisman N, Lusaus M, Nefussy B, Niv E, Comaneshter D, Hallack R, Drory VE. Do 
patients with amyotrophic lateral sclerosis (ALS) have increased energy 
needs? J Neurol Sci 2009; 279: 26-9. 
Voevodskaya O, Simmons A, Nordenskjold R, Kullberg J, Ahlstrom H, Lind L, 
Wahlund LO, Larsson EM, Westman E, Alzheimer's Disease Neuroimaging 
I. The effects of intracranial volume adjustment approaches on multiple 
regional MRI volumes in healthy aging and Alzheimer's disease. Front 
Aging Neurosci 2014; 6: 264. 
Vogt BA, Finch DM, Olson CR. Functional heterogeneity in cingulate cortex: the 
anterior executive and posterior evaluative regions. Cereb Cortex 1992; 2: 
435-43. 
Volkow ND, Wang GJ, Telang F, Fowler JS, Goldstein RZ, Alia-Klein N, Logan J, 
Wong C, Thanos PK, Ma Y, Pradhan K. Inverse association between BMI 
and prefrontal metabolic activity in healthy adults. Obesity (Silver Spring) 
2009; 17: 60-5. 
Woolley JD, Gorno-Tempini ML, Seeley WW, Rankin K, Lee SS, Matthews BR, 
Miller BL. Binge eating is associated with right orbitofrontal-insular-
striatal atrophy in frontotemporal dementia. Neurology 2007; 69: 1424-
33. 
Xu YF, Gendron TF, Zhang YJ, Lin WL, D'Alton S, Sheng H, Casey MC, Tong J, 
Knight J, Yu X, Rademakers R, Boylan K, Hutton M, McGowan E, Dickson 
DW, Lewis J, Petrucelli L. Wild-type human TDP-43 expression causes 
TDP-43 phosphorylation, mitochondrial aggregation, motor deficits, and 
early mortality in transgenic mice. J Neurosci 2010; 30: 10851-9. 
 
  
Page 26 of 76
ScholarOne, 375 Greenbrier Drive, Charlottesville, VA, 22901  Support (434) 964 4100
Brain
For Peer Review
 27
Figure Legends 
Figure 1: Scatter plot showing BMI values in bvFTD, AD and healthy controls 
Horizontal line represents mean +/- SD. bvFTD > AD and controls (p<.001) 
 
Figure 2. Resting and stressed heart rate in bvFTD, AD and healthy controls 
*bvFTD > AD (p= .028), ** bvFTD > Controls (p= .037), *** bvFTD > Controls (p= 
.001) 
 
Figure 3. Long term Actiheart results 
Mean sleeping heart rate. *** bvFTD > controls (p= .038); B) Mean activity counts 
per 24 hours. * AD< Controls (p=.05), ** bvFTD < Controls (p=.002) 
 
Figure 4. Regions showing significant correlations between cortical thinning and 
increasing resting heart rate in bvFTD and AD in whole brain imaging analyses. 
Statistical significance was set at p < .001 uncorrected for multiple comparisons. 
bvFTD = behavioural-variant frontotemporal dementia; AD = Alzheimer’s 
disease. 
 
Figure 5. Significant associations between cortical thickness in preselected ROIs and 
resting heart rate in bvFTD and HC. No significant associations were seen in AD and 
HC. Statistical significance was set at p < .0125 Bonferroni corrected for multiple 
comparisons. bvFTD = behavioural-variant frontotemporal dementia; HC = Healthy 
controls  
Supplementary Figure S1. Patterns of atrophy in bvFTD and AD versus healthy 
controls. Blue coloured regions show significant cortical thinning in the patient 
groups compared to controls (p < .05 FDR corrected). Red coloured regions show 
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significantly increased cortical thickness in the patient group compared to controls (p 
< .05 FDR corrected). 
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 Table 1. Demographics and clinical characteristics in bvFTD, AD and healthy controls 
 bvFTD 
(n = 19) 
AD 
(n = 13) 
HC 
(n =16) 
F value p value Post hoc  
Sex (F:M) 8:11 7:6 6:10 .83
†
 ns - 
Age (years) 62 ± 6.7 66 ± 8.2 65 ± 7.7 1.1 ns - 
BMI (kg/m
2
) 31.0 ± 6.9 23.6 ± 3.1 27.2 ± 5.9 9.6 p < .001 bvFTD > AD, HC 
ACE-III Total (max 100) 67.1 ± 20.7 64.3 ± 11.2 95.1 ± 1.9 21.6 p < .001 HC > patients 
Disease duration (years) 3.5 ± 1.9 4.7 ± 4.5 - .972# ns - 
FRS Rasch score^ -1.7 ± 1.2 -.02 ± 1.4 - 17.7# p < .01 bvFTD < AD 
APEHQ Total 68.9 ± 38.6 15.1 ± 20.2 - 4.1# p < .001 bvFTD > AD 
CBI Total 86.3 ± 24.7 51.3 ± 27.3 - 3.6# p < .01 bvFTD > AD 
CBI eating Total 9.3 ± 3.8 3.2 ± 4.5 - 4.1# p < .001 bvFTD > AD 
Treatment with cholinesterase 
inhibitor (n) 
2 9 0 22.2
†
 p < .001 AD > bvFTD and HC 
Treatment with chronotropic 
medication (n) 
2 1 1 .21
†
 ns - 
Current smokers (n) 2 0 2 1.7
†
 ns - 
Alcohol consumption (n) 8 5 10 2.1
†
 ns - 
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Values are expressed as mean ± standard deviation. bvFTD = behavioural-variant frontotemporal dementia; AD = Alzheimer’s disease; HC = 
healthy controls; BMI = body mass index; ACE-III = Addenbrooke’s Cognitive Examination-III; FRS = Frontotemporal dementia Rating Scale; 
APEHQ = Appetite and Eating Habits Questionnaire; CBI = Cambridge Behavioural Inventory; ns = not significant. 
† 
Chi-square test; # t-value; 
^The FRS provides logit scores ranging from 4.12 (very mild) to -4.99 (very severe). n= number of patients normally reporting alcohol and 
regular smokers. All alcohol consumption was within normal guidelines (see text). 
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Table 2. Measures of heart rate variability and autonomic function 
Values are expressed as mean ± standard deviation. Statistical analyses performed on Log transformed values. bvFTD = behavioural-variant 
frontotemporal dementia; AD = Alzheimer’s disease; HC = healthy controls; LF= low frequency; HF= high frequency; RMSSD= the square root 
of the mean squared difference of successive beat to beat intervals and a measure of vagal control of the heart 
  
 bvFTD 
(n = 19) 
AD 
(n = 13) 
HC 
(n =16) 
F value p value 
Resting LF .06 ± .02 .07 ± .02 .06 ± .01 .38 ns 
Resting HF .20 ± .08 .20 ± .07 .26 ± .07 2.6 ns 
Resting RMSSD 21.7 ± 11.1 29.2 ± 18.6 41.7± 35.1 2.7 ns 
Stressed LF .08 ± .10    .07 ± .02 .07 ± .03 .10 ns 
Stressed HF .21± .07 .22 ± .09 .22 ± .07 .08 ns 
Stressed RMSSD 23.3 ± 15.3 31.6 ± 17.9 41.7 ± 31.9 2.9 ns 
Rested LF/HF .34 ± .10 35 ± .20 .29 ± .14 1.7 ns 
Stressed LF/HF .48 ± .65 .38 ± .17 .37 ± .15 1.8 ns 
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Table 3. Average energy expenditure (kcal) per day in bvFTD, AD and healthy controls 
 bvFTD
a
 AD
a
 HC
a
 F value p value Post hoc 
Resting energy 
expenditure 
1656.9 ± 245.0 1356.4 ± 170.5 1442.1 ± 173.7 6.4 .005 bvFTD > HC (p = .045) 
bvFTD > AD (p = .005) 
Active energy 
expenditure  
676.9 ± 428.3 471.1 ± 278.8 525.1 ± 141.1 1.3 .291 - 
Diet induced 
thermogenesis 
259.2 ± 53.6 202.9 ± 43.9 218.3 ± 24.6 5.0 .013 bvFTD > HC (p = .035) 
bvFTD > AD (p = .013) 
Total energy 
expenditure 
2592.4 ± 533.9 2028.5 ± 440.9 2182 ± 246.4 5.0 .013 bvFTD > HC (p = .035) 
bvFTD > AD (p = .013) 
Physical activity level 1.6 ± .3 1.5 ± .1 1.5 ± .1 .6 .531 - 
Values are expressed as mean ± standard deviation. bvFTD = behavioural-variant frontotemporal dementia; AD = Alzheimer’s disease; HC = 
healthy controls. 
a
Missing data: Data missing for 7 bvFTD, 3 AD and 5 HC. 
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Table 4. Correlations between subcortical volumes and resting heart rate in bvFTD and AD 
 Thalamus Caudate Putamen Pallidum Hippocampus Amygdala Accumbens 
bvFTD -.349* -.334 -.342* -.197 -.529** -.352* -.446* 
AD .031 .173 .159 .257 .056 -.004 .026 
Values as expressed in Pearson’s correlation coefficient scores. * Denotes that the correlation is significant at the 0.05 level. ** Denotes that the 
correlation is significant at the 0.01 level. Significant correlations after correction for multiple comparisons are highlighted in bold.  bvFTD = 
behavioural-variant frontotemporal dementia; AD = Alzheimer’s disease. Statistical significance was set at p < .007 Bonferroni corrected for 
multiple comparisons.  
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Figure 1: Scatter plot showing BMI values in bvFTD, AD and healthy controls  
Horizontal line represents mean +/- SD. bvFTD > AD and controls (p<.001)  
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Figure 2. Resting and stressed heart rate in bvFTD, AD and healthy controls  
*bvFTD > AD (p= .028), ** bvFTD > Controls (p= .037), *** bvFTD > Controls (p= .001)  
 
 
254x190mm (72 x 72 DPI)  
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Figure 3. Long term Actiheart results  
Mean sleeping heart rate. *** bvFTD > controls (p= .038); B) Mean activity counts per 24 hours. * AD< 
Controls (p=.05), ** bvFTD < Controls (p=.002)  
 
 
254x190mm (72 x 72 DPI)  
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Figure 4. Regions showing significant correlations between cortical thinning and increasing resting heart rate 
in bvFTD and AD in whole brain imaging analyses. Statistical significance was set at p < .001 uncorrected 
for multiple comparisons. bvFTD = behavioural-variant frontotemporal dementia; AD = Alzheimer’s disease. 
 
369x410mm (96 x 96 DPI)  
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Figure 5. Significant associations between cortical thickness in preselected ROIs and resting heart rate in 
bvFTD and HC. No significant associations were seen in AD and HC. Statistical significance was set at p < 
.0125 Bonferroni corrected for multiple comparisons. bvFTD = behavioural-variant frontotemporal dementia; 
HC = Healthy controls  
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Supplementary table S1. Component sub-regions for cortical regions of interest analyses 
 Component sub-regions 
Prefrontal cortex Caudal middle frontal, rostral middle frontal, medial orbitofrontal, lateral orbitofrontal, pars opercularis, 
pars orbitalis and pars triangularis 
Mesial temporal cortex Fusiform, entorhinal, parahippocampal and lingual temporal regions 
Anterior cingulate cortex Caudal anterior cingulate and rostral anterior cingulate 
Insula Anterior (inferior and superior) and posterior insular regions 
Component sub-regions were identical in both hemispheres.  
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Supplementary Table S2. Measurements of subcortical brain regions in bvFTD, AD 
and healthy controls 
Brain measure bvFTD 
(n = 18) 
AD 
(n = 13) 
HC 
(n = 14) 
p value Post hoc 
Thalamus 4.5 ± 0.8 4.5 ± 0.6 5.0 ± 0.6 ns - 
Caudate 1.8 ± 0.7 2.2 ± 0.2 2.4 ± 0.4 0.01 bvFTD, AD < 
HC 
Putamen 2.8 ± 0.6 3.0 ± 0.4 3.6 ± 0.5 0.001 bvFTD, AD < 
HC 
Globus 
Pallidus 
0.9 ± 0.2 1.0 ± 0.1 1.0 ± 0.2 ns - 
Hippocampus 2.4 ± 0.6 2.2 ± 0.6 3.1 ± 0.3  < 0.001 bvFTD, AD < 
HC 
Amygdala 1.0 ± 0.3 0.9 ± 0.2 1.3 ± 0.2 0.001 bvFTD, AD < 
HC 
Nucleus 
Accumbens 
0.2 ± 0.1 0.3 ± 0.1 0.4 ± 0.1 < 0.001 bvFTD, AD < 
HC 
Values are expressed as a ratio of the total intracranial volume (mean ± standard 
deviation). ns = p > .05.; bvFTD = behavioural-variant frontotemporal dementia; AD 
= Alzheimer’s disease; HC = Healthy controls. 
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Abstract 
Abnormal eating behaviour and metabolic parameters including insulin resistance, 
dyslipidaemia and body mass index are increasingly recognized as important 
components of neurodegenerative disease and may contribute to survival. It has 
previously been established that behavioural variant frontotemporal dementia is 
associated with abnormal eating behaviour characterised by increased sweet 
preference. In this study, it was hypothesized that behavioural variant frontotemporal 
dementia might also be associated with altered energy expenditure. A cohort of 19 
patients with behavioural variant frontotemporal dementiabvFTD, 13 with 
Alzheimer’s disease and 16  (age- and sex- matched) healthy controls were studied 
using Actiheart devices (CamNtech, UK) to assess resting and stressed heart rate. 
Actiheart devices were fitted for 7 days to measure sleeping heart rate, activity levels, 
and resting, active and total energy expenditure. Using high resolution structural MRI 
the neural correlates of increased resting heart rate were investigated including 
cortical thickness and region of interest analyses. In behavioural variant 
frontotemporal dementia, resting (p=.001), stressed (p= .037) and sleeping heart rate 
(p=.038) were increased compared to controls, and resting heart rate (p=.020) 
compared to Alzheimer Disease patients. Behavioural variant frontotemporal 
dementia was associated with decreased activity levels compared to controls (p= .002) 
and increased resting energy expenditure (p= .045) and total energy expenditure 
(p=.035). Increased resting heart rate correlated with behavioural (Cambridge 
Behavioural Inventory) and cognitive measures (Addenbrooke’s Cognitive 
Examination).  Increased resting heart rate in behavioural variant frontotemporal 
dementia correlated with atrophy involving the mesial temporal cortex, insula, and 
amygdala, regions previously suggested to be involved exclusively in social and 
Formatted: Font: Italic
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emotion processing in frontotemporal dementia. These neural correlates overlap the 
network involved in eating behaviour in frontotemporal dementia suggesting, a 
complex interaction between eating behaviour, autonomic function and energy 
homeostasis. As such the present study suggests that increased heart rate and 
autonomic changes are prevalent in behavioural variant frontotemporal 
dementiabvFTD, and are associated with changes in energy expenditure. An 
understanding of these changes and neural correlates may have potential relevance to 
disease progression and prognosis. 
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Introduction 
Traditionally Frontotemporal dementia (FTD) has been viewed as a syndrome 
characterised by behavioural and cognitive changes, although increasingly it is 
beingeen recognised that there is involvement of networks that affect physiological 
processing including somatosensory processing including pain and temperature 
(Fletcher et al., 2015a; Fletcher et al., 2015b), autonomic processing (Ahmed et al., 
2015a; Guo et al., 2016), and neuroendocrine and metabolic changes (Ahmed et al., 
2014b; Ahmed et al., 2015b). In behavioural variant frontotemporal dementia 
(bvFTD), eating behavioural changes are common, including hyperphagia, increased 
sweet preference and changes in food preference that may be associated with  
increased body mass index (BMI), dyslipidaemia and insulin resistance (Ahmed et al., 
2014b). It has been suggested that given the prevalence of these eating behavioural 
changes, alterations in BMI are less than expected for the increased energy intake, 
suggesting changes in energy expenditure (Woolley et al., 2007; Ahmed et al., 
2016a). 
 
In several neurodegenerative diseases it is established that there are changes in 
metabolic parameters. One such condition is ALS, which shares a clinical and 
pathological overlap with FTD and where consistent changes have been found 
(Ahmed et al., 2016b), including increased resting energy expenditure in up to 50% of 
patients (Bouteloup et al., 2009; Vaisman et al., 2009). It has also been suggested that 
the hypermetabolic state (defined as increased energy expenditure) is intrinsically 
linked to the process of neurodegeneration with several animal models of TDP-43 and 
the C9ORF72 gene expansion exhibiting hypermetabolism and weight loss (Dupuis et 
al., 2004)
,
(Chiang et al., 2010; Shan et al., 2010; Xu et al., 2010; Koppers et al., 
2015).  
 
Given the significant overlap between FTD and ALS at a clinical, pathological and 
genetic level, it seems plausible that changes in energy expenditure may also be 
present in FTD (Ahmed et al., 2016b). In addition, the changes in appetite appear to 
exceed the minor increments in BMI and weight gain seen in bvFTD, suggesting 
increased energy expenditure may also contribute to the body weight changes seen in 
patients (Woolley et al., 2007; Ahmed et al., 2014a).  This is also suggested by the 
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fact that in studies measuring caloric intake in FTD, , adapted from obesity research, 
BMI does not correlate with caloric intake , suggesting other factors are at play 
(Ahmed et al., 2016a). Energy expenditure, which includes basal metabolic rate 
(amount of energy expended at rest) and active energy expenditure (a combination of 
activity levels and heart rate), has not been investigated in bvFTD. Intrinsically linked 
with energy expenditure are potentially alterations in autonomic activity including 
heart rate, heart rate variability, and sympathetic and parasympathetic drive .(Messina 
et al., 2013). Changes in the autonomic nervous system, particularly in the 
sympathetic nervous system have also been proposed to affect glucose and fat 
metabolism (Nonogaki, 2000; Penicaud et al., 2000).  Increases in heart rate have 
been found to predict an increase in metabolic rate and energy expenditure, via an 
increase in circulatory rate and oxygen consumptions (Berggren and Hohwu 
Christensen, 1950).  
 
Measurement of energy expenditure in free-living individuals is challenging. In this 
study, we used digital heart rate/activity monitoring (Brage et al., 2004; Brage et al., 
2005; Crouter et al., 2008) to examine changes in heart rate (rest, stressed and sleep), 
activity levels and energy expenditure and the potential correlations that this has to 
autonomic function in a large group of bvFTD patients, compared to a disease 
comparison group (Alzheimer’s disease, AD) and healthy controls. This approach has 
been used previously in genetic obesity research but not in patients with 
neurodegeneration (Pearce et al., 2013). The potential neurobiological underpinnings 
of increases in heart rate were further examined using structural MRI imaging to 
provide insight into the neural correlates controlling energy expenditure and 
autonomic function in FTD.  
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Methods 
 
Participants 
Thirty-two patients with dementia (19 bvFTD, 13 AD) were recruited from Forefront, 
Neuroscience Research Australia. These individuals were compared with 16 age- and 
sex-matched healthy controls. All patients underwent neurological review, cognitive 
assessment and met current clinical diagnostic criteria for probable bvFTD or AD 
(McKhann et al., 2001; Gorno-Tempini et al., 2011; McKhann et al., 2011; 
Rascovsky et al., 2011). Disease severity was established using the Frontal Rating 
Scale (FRS) (Mioshi et al., 2010). Controls were recruited from the Neuroscience 
Research Australia Volunteer database. Healthy controls scored above 88/100 on the 
Addenbrooke’s Cognitive Examination-III (Hsieh et al., 2013) and 0 on the sum of 
boxes score of the Clinical Dementia Rating scale (Morris, 1993). Exclusion criteria 
for patients and controls included concurrent psychiatric disturbance, other 
neurodegenerative conditions or neurological disorders and/or history of substance 
abuse.  
 
Patient medical history and medications 
Patients medical records and list of medications were obtained from their general 
practitioner. Given that the study measured heart rate variations, patients with a 
known cardiac rhythmic disorder e.g. atrial fibrillation, supraventricular tachycardia 
or conduction delays were excluded from the study (2 patients in total -1 bvFTD and 
1 AD patient).  Patient’s, their carers and controls were asked about their current 
smoking status and alcohol intake. 
 
 Ethics 
This study was approved by the South Eastern Sydney Local Health District and the 
University of New South Wales human ethics committees. Written informed consent 
was obtained from each participant and/or their primary caregiver. 
 
 
 
Physiological measurements: Actiheart device 
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Participitants were fitted with the Actiheart device (CamNtech, Cambridge, UK) a 
compact device designed to quantify heart rate, activity and energy expenditure 
(Brage et al., 2004; Brage et al., 2005; Crouter et al., 2008). The Actiheart has two 
clips which are attached directly to standard ECG electrodes. One electrode was 
attached to V1 on the chest (4th right intercostal space) and the second electrode was 
placed 10 cm away on the left mid-clavicular line. The number of R waves detected is 
recorded at 15-second epochs and from this the heart rate is derived. 
Simultaneously,A an internal triaxial accelerometer senses the frequency and intensity 
of the participant’s torso movements  including walking and pacing from which and 
activity counts are derived. When placed in short term mode, the Actiheart measures 
heart rate variability, heart rate and inter-beat interval (IBI) of the heart rate, with an 
epoch length of 15 seconds. Long term recordings in long term mode provide mean 
heart rate and activity levels over an epoch of 15 seconds and recordings can be made 
for up to 11 days (Brage et al., 2004; Brage et al., 2005; Crouter et al., 2008).  
 
Measurement of heart rate 
To measure resting and stressed heart rate participants wore the Actiheart in short 
term recording mode for a period of 6 hours following a standard protocol, described 
briefly. After arriving fasted (10 hours) and an initial period of introduction patients 
were given a set breakfast that measured caloric intake (Ahmed et al., 2016a), no 
caffeine or tea was included in this breakfast to avoid their chronotropic effects on 
heart rate., Pparticipants were then asked to rest in a lounge environment and their 
resting heart rate was obtained over a period of 30 minutes. Following this, 
participants were then taken into a room and took part in 2 hours of cognitive testing. 
The initial 30 minutes of this period was taken as the stressed heart rate. Resting and 
stressed heart rates and measures of autonomic function were obtained after entering 
the beat-to-beat RR interval data obtained by the Actiheart into Kubios HRV, an 
advanced and easy to use software for heart rate variability (HRV) analysis 
(Tarvainen et al., 2014). The following measures were obtained: the root mean 
squared of successive differences (RMSSD), which is a measure of vagal control of 
the heart (DeGiorgio et al., 2010); the low frequency (LF), which corresponds to the 
0.10Hz slow fluctuations of arterial pressure and reflects sympathetic and 
parasympathetic tone; the high frequency (HF) which corresponds to ~0.25 Hz 
fluctuations and is a measure of respiratory sinus arrhythmias and can be considered 
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an index of vagal modulation; and the LF/HF ratio which is used to indicate balance 
between sympathetic and parasympathetic tone.  
 
Long term activity  
Following the short term analyses, participants were fitted with the Actiheart in long 
term mode and asked to wear this at home for 7 days to provide continuous heart rate 
and activity monitoring. The participants wore the device continuously and were 
allowed to shower with the device. Carers were given instructions to refit the device if 
it became loose or was removed. From the long-term recording, sleeping heart rate 
and activity counts were calculated. 
 
Measurement of sleeping heart rate 
Sleeping heart rate was calculated over a period of 1 night. For each participant, the 1 
night was selected from the 7 day long term recording where a period of recording of 
uninterrupted sleep was obtained, between midnight and 5 am where no activity was 
detected. From this period, the average sleeping heart rate, minimum and maximum 
heart rate was calculated for each participant. Investigators were blinded to the patient 
ID and diagnoses for this selection. Sleeping heart rate was calculated over a period of 
1 night. For each participant, the 1 night was selected from the 7 day long term 
recording where a period of recording of uninterrupted sleep was obtained, with the 
most reliable recording. The patient ID and diagnoses was blinded for this selection. 
This was defined as a period between midnight and 5 am where no activity was 
detected. From this period, the average sleeping heart rate, minimum and maximum 
heart rate was calculated for each participant.  
 
Measurement of activity over 24 hours 
An average activity count over 24 hours was calculated for each participant. This was 
obtained by selecting a 24-hour period in the 7 day long-term recording where 
continuous recording was available for each patient. This was found to be day 2 in 
each patient as the Actiheart had been firmly attached and had not been removed, 
which tended to occur as the long term recording proceeded. The average activity 
counts for each patient over these 24 hours was obtained and expressed as an activity 
count per 24 hours. Significance levels between group means were examined after 
correcting for age and sex. 
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Measurement of energy expenditure 
The Actiheart measures heart rate and activity simultaneously and these data are 
transferred to the Actiheart software which uses a validated branched model equation 
(Brage et al., 2004; Brage et al., 2005) to derive active energy expenditure for each 
epoch using a combination of heart rate and activity. Using the branched model 
equation, group Cal JAP2007 (CamNtech, Cambridge, UK) measures of daily energy 
expenditure were calculated for each participant each day for 7 days and an average 
over this period obtained. The following measures were obtained: Activity Energy 
expenditure (AEE) derived from the branched model equation, which includes a 
combination of heart rate and activity measures; Resting energy expenditure (REE) 
derived from the Schofield equation, designed to measure basal metabolic rate 
adjusted for weight (Schofield, 1985); Dietary induced thermogenesis (DIT), 
estimated as 10% of total energy expenditure; Total energy expenditure (TEE) = 
REE+ AEE+ DIT; Physical activity level (PAL) = TEE/REE. 
 
Behavioural measurements  
In addition to measurements of heart rate variability, activity and energy expenditure, 
changes in eating behaviour were measured using caregiver-based questionnaires: the 
Appetite and Eating Habits Questionnaire (APEHQ) (Ikeda et al., 2002; Ahmed et al., 
2014a) and the Cambridge Behavioural Inventory (CBI) (Bozeat et al., 2000). These 
surveys were completed on the same day the short term recordings were obtained and 
were felt to be representative of intake over the proceeding 7 days when the long term 
recordings were obtained. The APEHQ provides measures of nicotine and alcohol 
consumption. Height and weight were measured barefoot and body mass index (BMI) 
calculated (weight in kilograms/height in metres squared). 
 
s barefootcalculatedweight in kilograms/height in metres squaredIn addition to 
measurements of heart rate variability, activity and energy expenditure, changes in 
eating behaviour were measured using caregiver-based questionnaires: the Appetite 
and Eating Habits Questionnaire (APEHQ) (Ikeda et al., 2002; Ahmed et al., 2014a) 
and the Cambridge Behavioural Inventory (CBI) (Bozeat et al., 2000). Height and 
weight were measured (shoes removed) to derive the body mass index (BMI, unit: 
kg/meter2). 
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Imaging 
MRI acquisition and preprocessing 
All participants underwent whole brain structural MRI with a 3 T Phillips scanner 
using a standard 8-channel head coil. 3D high-resolution turbo field echo T1-
weighted sequences were acquired with the following parameters: coronal orientation, 
matrix 256 × 256, 200 slices, 1 mm2 in-plane resolution, slice thickness 1 mm, echo 
time/repetition time 2.6/5.8 ms, flip angle α=8°. MRI scans were obtained on the 
same day as the physiological and behavioural assessment. 
 
Before analyses, the two T1 volumes were merged and averaged to increase the signal 
to noise ratio and the grey matter-white matter contrasts in brain structures. 
FreeSurfer software, version 5.3.0 (http://surfer.nmr.mgh.harvard.edu) was used for 
surface-based cortical processing (Dale et al., 1999; Fischl et al., 1999) using standard 
methods (Fischl and Dale, 2000). Cortical thickness was smoothed with a 20 mm full-
width at half-height Gaussian kernel. This level of blurring kernel was chosen to 
reduce the impact of imperfect alignment between cortices and thereby improve the 
signal-to-noise ratio (Lerch and Evans, 2005).  
 
In addition, the following subcortical structures were automatically segmented and 
extracted for both hemispheres: thalamus, caudate, putamen, globus pallidus, 
hippocampus, amygdala, and nucleus accumbens. For these subcortical structures, 
measurements from both hemispheres were averaged and adjusted for total 
intracranial volume, in line with previous methodology (Voevodskaya et al., 2014).  
 
All the resulting images were visually inspected and manually corrected in the event 
of tissue segmentation errors. One bvFTD patient and 2 healthy controls were 
excluded due to excessive surface or subcortical segmentation errors. Thus, 18 
bvFTD, 13 AD and 14 healthy controls were included in the imaging analyses. 
 
Statistical analyses 
 
Demographic and physiological variables 
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Analyses were conducted using IBM SPSS statistics (version 21.0). Kolmogorov-
Smirnov tests were run to determine suitability of variables for parametric analyses. 
One-way analyses of variance (ANOVA), followed by Tukey post hoc tests, were 
used to determine group differences in demographic and clinical variables (age, ACE-
R). Categorical variables were analyzed using chi-square analyses. Independent t-tests 
were used to determine differences between bvFTD and AD for disease duration, 
abnormal behaviour (total CBI, CBI behavioural) and eating behaviour (APEHQ, CBI 
eating, and BMI) (p ≤ 0.05 regarded as significant). Measurements of heart rate 
(resting and stressed), autonomic function (resting and stressed LF, HF, RMSSD after 
log transformation), activity counts and energy measures (REE, AEE, DIT, PAL) 
were also explored using ANOVA, followed by Tukey post hoc tests. The 
relationship between resting heart rate and disease duration, BMI, eating behaviour 
(APEHQ total score) cognitive status (ACE-III) and behavioural measures (CBI total, 
eating and behavioural) were further explored using Pearson rank correlations 
corrected for multiple comparisons (p ≤ 0.01 regarded as significant). 
 
Imaging data analyses 
For cortical thickness, sets of vertex-by-vertex analyses were performed using general 
linear models aimed to examine differences in cortical thickness between groups and 
then to estimate the neural correlates for the physiological variables where bvFTD 
showed significant differences with both AD and healthy controls (resting heart rate 
and stressed heart rare). In the first set of analyses, overall cortical thickness of both 
hemispheres was modelled including cortical thickness as a dependent variable and 
group (bvFTD, AD, healthy controls) as an independent variable. In the second set of 
analyses, we created separate linear models, one for each physiological variable under 
examination. Each model included the following repressors: group (bvFTD, AD, 
healthy controls), the physiological variable (resting heart rate, stressed heart rare) 
and the interaction between group and the physiological variable. To determine 
physiological associations with cortical thickness specific to diagnostic group, we 
focused on the interaction effect between each diagnosis and each physiological 
variable. Correlations between physiological variables and cortical thickness were 
investigated first by combining all participants (behavioural variant FTD, , 
Alzheimer’s disease, controls) and then in each patient group combined with controls, 
to identify neural correlates of resting and stressed heart rate to each patient group.. 
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Since the groups were matched at baseline for age, sex and duration of disease, no 
covariates were included in the models. Statistical significance was set at p = 0.001 
uncorrected for multiple comparisons. In addition, we used a conservative cluster 
extent threshold of k > 50 mm
2
. This approach is designed to minimize Type I error 
while balancing the risk of Type II error (Lieberman and Cunningham, 2009). 
For the subcortical regions, group comparisons of subcortical volumes between 
bvFTD, AD and healthy controls were performed using ANOVA. Post hoc analyses 
were corrected for multiple comparisons using a Sidak adjustment. Next, in order to 
uncover the subcortical grey matter correlates of resting heart rate and stressed heart 
rate, correlations were investigated using the same approach outlined above. Pearson 
two-tailed correlational analyses were conducted with Bonferroni correction for 
multiple comparisons (p < ∝/ = .007).  
 
Region of interest analyses 
In addition to the whole-brain analyses, a set of cortical regions of interest (ROI) were 
selected and computed and averaged from the regional parcellations provided by 
FreeSurfer for both hemispheres. These regions were selected according to previous 
findings in the literature examining associations between autonomic function (e.g., 
pain and temperature and heart rate) and brain regions in bvFTD and AD and normal 
controls (Critchley et al., 2003; Jones, 2011; Fletcher et al., 2015a). The regions 
selected included the prefrontal, mesial temporal and anterior cingulate cortices, and 
the insula. Details on the computation of these measurements can be found in 
Supplementary Table S1. Pearson two-tailed correlations were used to examine 
associations between these ROIs and the resting and stressed heart rate. These 
analyses were Bonferroni corrected to control for multiple comparisons (p < ∝/ = 
.0125).  
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Results 
 
Participants groups were representative of the diseases studied and did not differ in 
sex distribution, age or disease duration (Table 1, all p values > 0.365). Group 
differences were observed on measures of cognition (ACE-III), behavioural measures 
and eating behaviour (Table 1) and were in keeping with the known behaviour of the 
diagnostic groups. On the ACE-III as expected the patient groups scored lower than 
controls (p < .001). The bvFTD group was more functionally impaired relative to AD 
(FRS; t = 3.3, p = .03). The bvFTD group as expected scored higher than the AD 
group on the total CBI score (t = 3.6, p = .001), and CBI behavioural score (t = 4.1, p 
< .001).  
 
Medications, smoking and alcohol intake (Table 1) 
As expected, a higher number of AD patients were on cholinesterase inhibitors (9 
patients) compared to the bvFTD (2 patients) and control (no patient) groups. There 
was no difference in the number of patients treated with a medication likely to affect 
heart rate and cardiac conduction (e.g. beta blocker, calcium channel blocker) 
between the groups. One bvFTD patient was on stable and adequate thyroxine 
treatment. Two bvFTD patients and 2 control subjects were current smokers. Eight 
bvFTD patients carers reported that they consumed alcohol normally, less than 
weekly in 4 and several times per week in 4. Ten control subjects reported alcohol 
consumption, 4 less than weekly and 6 several times a week. Five AD patients 
reported alcohol intake regularly, 2 several times a week and 3 less than weekly. No 
patient or control participant stated that they consumed more alcohol than the 
recommended amount by the Australian National Health and Medical research 
council. 
 
 
Eating behaviour and BMI 
On both the APEHQ and CBI eating score  and CBI eating total (t = 4.1, p < .001). 
tThe bvFTD group showed more severe eating disturbance based on caregiver surveys 
compared with AD (t = 4.1, p < .001). The bvFTD group had an increased BMI 
(Figure 1) compared to the AD (p = .001) and Control groups (p = .008) (Table 1).   
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[INSERT FIGURE 1 HERE] 
 
Heart rate and autonomic function 
Significant group differences were present for both resting (F= 8.6, p = .001) and 
stressed (F= 3.2, p = .047) heart rate measures. The bvFTD group (mean = 81.8 bpm 
had an increased resting heart rate compared to both the control (mean= 68.5 p = 
.001) and AD groups (mean = 72.5, p = .020) and an increased stressed heart rate 
compared to the control group (bvFTD = 81.5, AD= 76.1, Control= 71.9; p = .037) 
(Figure Figure 21). On measures of autonomic function (Table 2), no significant 
group differences were detected; however, a trend for the bvFTD group to have a 
decreased RMSSD value, in both resting (p = .076) and stressed states (p = .063) was 
present 
 
[INSERT FIGURE 21 HERE] 
 
Correlations of resting heart rate with behavioural measures 
When all groups were combined, resting heart rate was positively correlated with 
behavioural and eating changes as reflected by the CBI total (r  = .417, p = .004), CBI 
behavioural (r  = .451, p = .001), and total CBI eating score (r  = .307, p = .01), and 
negatively correlated with cognitive function on the ACE-III (r = -.314, p = .01), 
functional ability on the FRS (r  = -.308, p =.05). As in prior studies, an increased 
BMI correlated with behavioural changes on the CBI total (r  = .369, p = .01), CBI 
behavioural (r  = .334, p = .01), and total CBI eating score (r  = .397, p = .006), and 
the APEHQ (r  = .461, p = .01). BMI did not correlate with resting heart rate (r  = 
.206, p = .160). 
 
Long term Actiheart recordings 
Long-term recordings over 7 days were obtained for 121 bvFTD, 10 AD, and 119 
control participants to measure sleeping heart rate and activity levels. Several bvFTD 
patients refused to wear the Actiheart or when at home disposed of it. The patients in 
the subset analyses did not differ from the larger group in which short term recordings 
and imaging correlation were conducted. 
 
Sleeping heart rate 
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As with resting and stressed heart rate significant group differences were also 
detected in mean sleeping heart rate (Figure 32a) (F = 3.9, p = .032) with the bvFTD 
group (mean= 71.6 bpm) having an increased sleeping heart rate compared to the 
control group (mean= 61.5 p = .038) and a trend compared to the AD group (mean = 
62.8 p = .085).  No group differences (F = 1.4 p = .270) in mean minimum heart rate 
were detected between the bvFTD (58.9 ± 7.3 bpm), AD (54.7 ± 8.2) and control 
groups (55.1 ± 5.2). By contrast, the bvFTD group (100.2 ± 13.9) had an increased 
maximum heart rate compared to the control group (95.7 ± 14.3 bpm; F= 4.2 p= 
.025). 
 
Activity levels 
Group differences were detected on activity counts (Figure 32b) over a 24 hour 
period, after correcting for age and sex. Contrary to what was expected both the 
bvFTD (p = .002) and AD groups (p= .05) showed significantly decreased activity 
counts per hour compared with the controls, suggesting particularly that the bvFTDis 
group has reduced activity levels. 
 
[INSERT FIGURE 32 HERE] 
 
Energy expenditure 
On examination of energy expenditure group differences were present (Table 3), with 
the bvFTD group having an increased resting energy expenditureREE compared to 
the control (p= .045) and AD (p= .005) groups. The bvFTD group also had an 
increased diet induced thermogenesisDIT and total energy expenditureTEE compared 
to the other groups. Despite the finding of decreased activity counts in bvFTD, no 
significant group differences in active energy expenditureAEE were observed 
(calculated as a combination of heart rate and activity levels), suggesting that the 
decreased activity counts in bvFTD may not have affected the active energy 
expenditure,AEE due to the increased heart rate seen in this group. 
 
Imaging analyses 
 
Atrophy analyses 
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Group comparisons between each clinical group and controls revealed the 
characteristic profiles of brain atrophy previously reported as consistent with a 
diagnoses of bvFTD and AD. These results are presented in Supplementary Figure S1 
and Supplementary Table S2. In brief, bvFTD patients showed atrophy in the insula 
and inferior frontal and anterior temporal cortices. In contrast, AD patients 
demonstrated widespread and bilateral atrophy involving parietal, temporal and to a 
lesser extent frontal regions, compared with controls. In addition, both clinical groups 
showed atrophy in all subcortical structures measured compared with controls, with 
the exception of the thalamus and the globus pallidus (Supplementary Table S2). The 
amount of atrophy in these structures was of similar magnitude in bvFTD and AD.  
 
Neural correlates of resting and stressed heart rate 
Unbiased whole brain analyses yielded a significant association between increasing 
resting heart rate and cortical thinning in the right posterior cingulate and right 
inferior parietal cortex when combining  bvFTD and AD patients together (Figure 
43).  
 
[INSERT FIGURE 43 HERE] 
 
In bvFTD but not in AD, increased resting heart rate was associated with volume 
reductions in the thalamus (r = -.349, p = .05), caudate (r = -.334, p = .06), putamen (r 
= -.342, p = .05), hippocampus (r = -.529, p = .002), amygdala (r = -.353, p = .04) and 
nucleus accumbens (r = -.446, p = .01), structures which are known in normal 
controls to be involved in autonomic regulation. Of these correlations, only the 
association between reduced hippocampal volume and increased resting heart rate 
survived conservative Bonferroni correction for multiple comparisons (Table 4).  
 
[INSERT TABLE 4 HERE] 
 
 
Also in bvFTD but not in AD, ROI analyses uncovered significant associations 
between increased resting heart rate and cortical thinning in the mesial temporal 
cortex (r = -.520, p = .002) and the insula (r = -.490, p = .004). Additional correlations 
were also found with the prefrontal (r = -.359, p = .04) and anterior cingulate cortices 
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(r =-.352, p = .04), again structures known to be integral to autonomic control, 
although these did not survive correction for multiple comparisons (Figure 54). 
 
[INSERT FIGURE 54 HERE] 
 
No further significant associations were found between stressed heart rate and cortical 
or subcortical regions in either bvFTD or AD. 
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Discussion 
 
Behavioural variant frontotemporal dementia is characterized by an increased resting, 
stressed and sleeping heart rate compared to both AD and healthy controls. Given that 
changes in heart rate are indicative of changes in metabolic rate and energy 
expenditure (Berggren and Hohwu Christensen, 1950; Penzel et al., 2003), via the 
relationship between pulse rate, circulation and oxygen consumption, these changes 
suggest the presence of a hypermetabolic state in bvFTD. Behavioural variant 
frontotemporal dementia is also characterised by increased resting energy 
expenditure, total energy expenditure and decreased activity levels. . Changes in heart 
rate correlate to a neural network involving the mesial temporal cortex, insula, 
nucleaus accumbens and cingulate.  
 
In ALS, which overlaps clinically, pathologically and genetically with bvFTD, 
changes in heart rate (Chida et al., 1989)  and a state of hypermetabolism (Desport et 
al., 2001) have also been documented, with an increased heart rate on formal 
autonomic function testing being found secondary to increased sympathetic and 
decreased parasympathetic input (Chida et al., 1989). In the present study, indications 
of decreased vagal tone and parasympathetic input in bvFTD were also present, with a 
trend towards decreased RMSSD, which is a measure of heart rate variability and 
reflects the integrity of vagus nerve mediated control of the heart (DeGiorgio et al., 
2010). (Nonogaki, 2000; Messina et al., 2013)There is good experimental evidence in 
rodents and humans that changes in autonomic tone induced directly or indirectly (for 
example through thyroid disorders) affect energy expenditure and peripheral 
metabolism (lipolysis) (Nonogaki, 2000; Penicaud et al., 2000; Messina et al., 2013). 
It is therefore readily plausible that changes in heart rate may alter energy expenditure 
in patients with FTD. However, this remains to be established in studies using indirect 
calorimetry although we note these can be quite challenging in patients with complex 
behavioural problems.  
 
 
Anecdotally, patients with bvFTD are described as being restless with pacing 
behaviour or alternatively to show inertia (Piguet et al., 2009), but activity levels have 
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not been systematically examined. It has also been suggested that bvFTD patients 
may not show the degree of weight gain expected in the setting of their increased 
eating due to hyperactivity (Woolley et al., 2007). Here, however, we have 
demonstrated that bvFTD patients show decreased activity levels compared with AD 
patients and healthy controls. This decreased activity may be secondary to the 
increased apathy seen in this disorder, which has been. r, related to atrophy in the 
right caudate, ventral striatum and cortical basal ganglia circuits (Eslinger et al., 
2012), brain regions commonly affected in bvFTD. 
 
In addition, bvFTD patients exhibited an increased resting energy expenditure 
(REE)REE, a measure of the resting metabolic rate, and  total energy expenditure. 
The increased REE and basal metabolic state may in part be explained by the 
increased body mass index seen in the bvFTD group, but may also be influenced by 
the presence of a hypermetabolic state. This finding is in keeping with results in ALS 
showing that ALS patients may show tTotal energy EexpenditureE well above their 
REE and activity levels and potentially secondary to hypermetabolism (Kasarskis et 
al., 2014). 
 
Increased resting heart rate was also found to correlate with increasing cognitive 
impairment (lower ACE-III scores) and increasing behavioural impairment (higher 
CBI scores). Changes in neurodegeneration have been linked to alterations in energy 
homeostasis with animal models of ALS and FTD associated with weight loss and 
hypermetabolism (Dupuis et al., 2004; Chiang et al., 2010; Shan et al., 2010; Xu et 
al., 2010). Additional studies in patients with the language variants of FTD, 
particularly Semantic dementia may be informative. . It is suspected that there may 
well be changes in energy expenditure in semantic dementia given that they have 
similar changes in BMI to bvFTD in the contenxt of eating behavioural changes 
(Ahmed et al 2014) and a similar pathology to ALS (TDP-43), where energy changes 
are prominent (Dupuis et al., 2011; Ahmed et al., 2016b). 
 
It may be suggested that T the changes seen in heart rate in bvFTD i.e. an increased 
resting and stressed and sleeping heart may be secondary to environmental factors 
such as caffeine, nicotine or alcohol consumption, rather than physiological changes. 
This seems unlikely given that there was no difference in reported smoking frequency 
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and alcohol consumption between the groups, with only 2 bvFTD and 2 control 
subjects reported to be smokers, and similar rates of reported regular alcohol 
consumption, which were within recommended national guidelines.  It is also unlikely 
that caffeine and tea intake would have affected the short term heart rate recordings 
(resting and stressed heart rate) as patients attended fasted and then received a 
breakfast with no caffeine available. Caffeine and tea intake was not measured during 
the long term measurements and this could potentially confound the long term 
recordings, however this is unlikely given that resting heart was elevated in the setting 
of the controlled environment of no caffeine consumption for the short term 
recordings. . When considering these results, it should be noted that changes in heart 
rate may potentially be related to decreased physical fitness associated with increasing 
disease severity, decreased activity secondary to apathy or loss of independence. 
However as increases in heart rate did not correlate with BMI changes, this suggests 
that changes in heart rate are far more complex than just being related to physical 
fitness and likely represent a complex interaction between atrophy in key cortical 
areas affecting autonomic function, and energy expenditure, and are likely to be 
centrally rather than peripherally mediated It is also unlikely that the changes in heart 
rate are simply related to decreased physical fitness associated with increasing disease 
severity, as increases in heart rate did not correlate with BMI changes, suggesting that 
changes in heart rate are far more complex and likely represent a complex interaction 
between atrophy in key cortical areas affecting autonomic function, and energy 
expenditure, and are likely to be centrally rather than peripherally mediated.  
 
 
Whilst medications that potentially affect heart rate may affect the results of our 
study, there was no significant difference in use of chronotropic drugs between the 
groups. Cholinesterase inhibitor treatment has been linked with bradycardia in a small 
proportion of patients (Hernandez et al., 2009). Despite the high number of AD 
patients on this medication, this is unlikely to be a confounding issue in the current 
study as the mean resting heart rate in the AD group was above that seen in the 
normal control population  Medication usage that potentially affects heart rate is also 
unlikely to be confounding the results as there was no significant difference in use of 
chronotropic drugs between the groups. Cholinesterase inhibitor treatment has been 
linked with bradycardia in a small proportion of patients.(Hernandez et al., 2009) 
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Despite the high number of AD patients on this medication, this is unlikely to be a 
confounding issue in the current study as the mean resting heart rate in the AD group 
was above that seen in the normal control population.  
(Hernandez et al., 2009) 
In this study, an increased resting heart rate in bvFTD was found to correlate with 
atrophy of the mesial temporal cortex including hippocampus, together with the 
amygdala, nucleus accumbens, insula and cingulate, all structures known to be 
integral to autonomic control of the human body and involving the limbic system, 
which is known to be involved in FTD (Seeley et al., 2008; Jones, 2011). In bvFTD, 
pathological changes in these structures have traditionally being linked to disturbance 
of memory and social cognition (Galton et al., 2001; Kipps et al., 2009; Kumfor et al., 
2013; Irish et al., 2014). Recently decreased cardiac vagal tone has been found in 
bvFTD and linked to reduced agreeableness and a network involving left-lateralized 
functional and structural frontoinsular and cingulate cortex deficits (Guo et al., 2016). 
Our findings suggest that in addition these structures may have a fundamental role in 
autonomic, energy expenditure and metabolic control in bvFTD. 
 
The anterior cingulate cortex, has been shown to participate in decision making, 
response selection (Devinsky et al., 1995), anticipation of reward, task reinforcement 
(Amiez et al., 2006; Rushworth et al., 2007) and in controlling visceromotor, 
endocrine and skeletomotor outputs (Vogt et al., 1992), potentially via integration of 
cognitive with autonomic information (Critchley et al., 2001). In healthy individuals, 
activity of the anterior cingulate cortex has been associated with increased body mass 
index (Volkow et al., 2009) suggesting a role for this structure in regulating eating 
and metabolism. It has also been shown that the anterior cingulate cortex is related to 
sympathetic modulation of heart rate dissociable from cognitive and motor related 
activity and that focal damage to brain region can result in both an increase and 
decrease in heart rate (Critchley et al., 2003). Although the cingulate cortex responds 
to emotional stimuli, it is also metabolically active at rest (Raichle et al., 2001; Luu 
and Posner, 2003), suggesting a pivotal role for this brain region in the normal 
physiological control of the body. 
 
Several studies and meta-analyses have shown the integral role that the amygdala 
plays in controlling heart and heart rate variability, particularly in times of emotional 
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response and threat (Thayer et al., 2012). The fact that the amygdala correlated with 
increased resting heart rate in bvFTD in the current study, suggests that this structure 
plays a role in the physiological and metabolic changes seen in bvFTD and not simply 
in response to emotional stimuli. The insula is involved early in the course of bvFTD 
(Seeley et al., 2008) and has been found on voxel-based morphometry (VBM) to 
correlate to pain and temperature symptoms in bvFTD, with the suggestion that it 
forms a network hub for sensory homeostatic signalling with the thalamus in bvFTD. 
(Fletcher et al., 2015a). Our findings suggest that the insula also forms an important 
part of the network involved in heart rate, energy expenditure, autonomic and 
metabolic control in bvFTD  
 
It is of interest that several of the structures found to correlate with increased resting 
heart rate namely the cingulate cortex, insula and amygdala have been found to 
correlate with hyperphagia and abnormal eating behaviour in bvFTD. Moreover all of 
these structures have connections to the hypothalamus (Kullmann et al., 2014; Ahmed 
et al., 2016a), which has been found to be atrophied in bvFTD and correlate with BMI 
measures (Ahmed et al., 2015b). This suggests a complex interaction between 
cortical, subcortical structures and the hypothalamus in the control of eating 
behaviour, heart rate and energy expenditure all of which are affected in bvFTD. 
 
In AD, by contrast, it has been speculated that weight loss occurs with disease 
progression and low body weight has previously being correlated to mesial temporal 
cortex atrophy (Grundman et al., 1996). Further studies are required using large 
samples documenting longitudinal weight loss and the neural correlates to ascertain 
the commonalities and differences controlling weight between FTD and AD. Further 
studies using direct measurements of energy intake and expenditure in large numbers 
of patients and age-and BMI-matched controls (both normal and AD patients) 
longitudinally are required to assess the relative contributions of these parameters to 
weight changest gain in FTD.  Further studies are required using large samples 
documenting longitudinal changes in weight, energy expenditure and eating 
behaviour, and the neural correlates to ascertain the commonalities and differences 
controlling weight between FTD, and its variants, and AD.  It will also important to 
examine energy expenditure between the different forms of FTD (behavioural variant 
versus semantic dementia), given the differences in eating behaviour that are seen 
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between these conditions (Ahmed et al., 2016a). It is suspected that there may well be 
changes in energy expenditure in semantic dementia given that they have similar 
changes in BMI to bvFTD, in the setting of eating behaviour change (Ahmed et al., 
2014a) and a similar pathology (TDP-43) to ALS, where energy changes are 
prominent (Dupuis et al., 2004; Dupuis et al., 2011).  Longitudinal studies will help to 
show the complex relationship between weight, eating behaviour and energy 
metabolism.(Ahmed et al., 2016a). 
 
Behavioural variant frontotemporal dementia is characterized by an increased resting 
and sleeping heart rate indicative of changes in metabolic rate and resting  energy 
expenditureREE which may moderate the weight gain in the setting of prominent 
changes of eating behaviour. BvFTD is also accompanied by decreased activity levels 
suggesting that energy expenditure changes are likely secondary to intrinsic 
processes, driven by changes in heart rate, rather than by an increase in activity levels. 
Changes in heart rate correlated with atrophy of cingulate and limbic systems 
including the insula and amygdala, which overlap with networks known to control 
eating behaviour in bvFTD. Further studies are required to document changes in heart 
rate and energy expenditure across the ALS-FTD spectrum and in presymptomatic 
genetic cohorts, to ascertain when changes first develop during the course of the 
disease.  An approach combining longitudinal clinical studies and animal models of 
FTD and ALS will prove crucial. The current study is the first study to measure the 
interaction between heart rate, autonomic function and energy expenditure in FTD, 
using novel methods from obesity research that allow for measurements over both 
short term and long term (7 days) in the patient’s normal environment. Further studies 
using indirect calorimetry to measure basal metabolic rate and total energy 
expenditure are warranted to further examine these interactions. An understanding of 
the potential changes in energy expenditure, autonomic function and their neural 
correlates including involvement of the mesial temporal cortex, cingulate cortex, 
amygdala and insula in energy expenditure aids in the physiological phenotyping of 
FTD and extends our knowledge of the disease beyond cognition and emotion 
processing.  
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Figure Legends 
Figure 1: Scatter plot showing BMI values in bvFTD, AD and healthy controls 
Horizontal line represents mean +/- SD. bvFTD > AD and controls (p<.001) 
 
Figure 21. Resting and stressed heart rate in bvFTD, AD and healthy controls 
*bvFTD > AD (p= .028), ** bvFTD > Controls (p= .037), *** bvFTD > Controls (p= 
.001) 
Figure 32. Long term Actiheart results 
A) Mean sleeping heart rate. *** bvFTD > controls (p= .038); B) Mean activity 
counts per 24 hours. * AD< ControlsbvFTD, AD (p=.05), ** bvFTD < Controls 
(p=.002) 
Figure 43. Regions showing significant correlations between cortical thinning 
and increasing resting heart rate in bvFTD and AD in whole brain imaging 
analyses. Statistical significance was set at p < .001 uncorrected for multiple 
comparisons. bvFTD = behavioural-variant frontotemporal dementia; AD = 
Alzheimer’s disease 
Figure 54. Significant associations between cortical thickness in preselected ROIs 
and resting heart rate in bvFTD and HC. No significant associations were seen in AD 
and HC. Statistical significance was set at p < .0125 Bonferroni corrected for multiple 
comparisons. bvFTD = behavioural-variant frontotemporal dementia; HC = Healthy 
controls  
 
Supplementary Figure S1. Patterns of atrophy in bvFTD and AD versus healthy 
controls. Blue coloured regions show significant cortical thinning in the patient 
groups compared to controls (p < .05 FDR corrected). Red coloured regions show 
significantly increased cortical thickness in the patient group compared to controls (p 
< .05 FDR corrected). 
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 Table 1. Demographics and clinical characteristics in bvFTD, AD and healthy controls 
 bvFTD 
(n = 19) 
AD 
(n = 13) 
HC 
(n =16) 
F value p value Post hoc  
Sex (F:M) 8:11 7:6 6:10 .83
† ns - 
Age (years) 62 ± 6.7 66 ± 8.2 65 ± 7.7 1.1 ns - 
BMI (kg/m
2
) 31.0 ± 6.9 23.6 ± 3.1 27.2 ± 5.9 9.6 p < .001 bvFTD > AD, HC 
ACE-III Total (max 100) 67.1 ± 20.7 64.3 ± 11.2 95.1 ± 1.9 21.6 p < .001 HC > patients 
Disease duration (years) 3.5 ± 1.9 4.7 ± 4.5 - .972# ns - 
FRS Rasch score^ -1.7 ± 1.2 -.02 ± 1.4 - 17.7# p < .01 bvFTD < AD 
APEHQ Total 68.9 ± 38.6 15.1 ± 20.2 - 4.1# p < .001 bvFTD > AD 
CBI Total 86.3 ± 24.7 51.3 ± 27.3 - 3.6# p < .01 bvFTD > AD 
CBI eating Total 9.3 ± 3.8 3.2 ± 4.5 - 4.1# p < .001 bvFTD > AD 
Number Treatmented with 
cholinesterase inhibitor (n) 
2 9 0 22.2
†
 p < .001 AD > bvFTD and HC 
Number tTreatmented with 
Beta-blocker or calcium 
channel blocker (n) 
2 1 1 .21† ns - 
Current Ssmokers (n) 2 0 2 1.7
† ns - 
Alcohol consumption (n) 8 5 10 2.1
†
 ns - 
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Values are expressed as mean ± standard deviation. bvFTD = behavioural-variant frontotemporal dementia; AD = Alzheimer’s disease; HC = 
healthy controls; BMI = body mass index; ACE-III = Addenbrooke’s Cognitive Examination-III; FRS = Frontotemporal dementia Rating Scale; 
APEHQ = Appetite and Eating Habits Questionnaire; CBI = Cambridge Behavioural Inventory; ns = not significant. 
† 
Chi-square test; # t-value; 
^The FRS provides logit scores ranging from 4.12 (very mild) to -4.99 (very severe). N= number of patients normally reporting alcohol and 
regular smokers. All alcohol consumption was within normal guidelines (see text). 
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Table 2. Measures of heart rate variability and autonomic function 
Values are expressed as mean ± standard deviation. Statistical analyses performed on Log transformed values. bvFTD = behavioural-variant 
frontotemporal dementia; AD = Alzheimer’s disease; HC = healthy controls; LF= low frequency; HF= high frequency; RMSSD= the square root 
of the mean squared difference of successive beat to beat intervals and a measure of vagal control of the heart 
  
 bvFTD 
(n = 19) 
AD 
(n = 13) 
HC 
(n =16) 
F value p value 
Resting LF .06 ± .02 .07 ± .02 .06 ± .01 .38 ns 
Resting HF .20 ± .08 .20 ± .07 .26 ± .07 2.6 ns 
Resting RMSSD 21.7 ± 11.1 29.2 ± 18.6 41.7± 35.1 2.7 ns 
Stressed LF .08 ± .10    .07 ± .02 .07 ± .03 .10 ns 
Stressed HF .21± .07 .22 ± .09 .22 ± .07 .08 ns 
Stressed RMSSD 23.3 ± 15.3 31.6 ± 17.9 41.7 ± 31.9 2.9 ns 
Rested LF/HF .34 ± .10 35 ± .20 .29 ± .14 1.7 ns 
Stressed LF/HF .48 ± .65 .38 ± .17 .37 ± .15 1.8 ns 
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Table 3. Average energy expenditure (kcal) per day in bvFTD, AD and healthy controls 
 bvFTD
a
 AD
a
 HC
a
 F value p value Post hoc 
Resting energy 
expenditureEE  
1656.9 ± 245.0 1356.4 ± 170.5 1442.1 ± 173.7 6.4 .005 bvFTD > HC (p = .045) 
bvFTD > AD (p = .005) 
Active energy 
expenditureEE  
676.9 ± 428.3 471.1 ± 278.8 525.1 ± 141.1 1.3 .291 - 
Diet induced 
thermogenesisIT  
259.2 ± 53.6 202.9 ± 43.9 218.3 ± 24.6 5.0 .013 bvFTD > HC (p = .035) 
bvFTD > AD (p = .013) 
Total energy 
expenditureEE  
2592.4 ± 533.9 2028.5 ± 440.9 2182 ± 246.4 5.0 .013 bvFTD > HC (p = .035) 
bvFTD > AD (p = .013) 
Physical activity 
levelAL  
1.6 ± .3 1.5 ± .1 1.5 ± .1 .6 .531 - 
Values are expressed as mean ± standard deviation. bvFTD = behavioural-variant frontotemporal dementia; AD = Alzheimer’s disease; HC = 
healthy controls; REE = Resting Energy Expenditure; AEE = Activity Energy Expenditure; DIT = Dietary Induced Thermogenesis; TEE = Total 
Energy Expenditure ; PAL = Physical activity level. 
a
Missing data: Data missing for 7 bvFTD, 3 AD and 5 HC. 
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Table 4. Correlations between subcortical volumes and resting heart rate in bvFTD and AD 
 Thalamus Caudate Putamen Pallidum Hippocampus Amygdala Accumbens 
bvFTD -.349* -.334 -.342* -.197 -.529** -.352* -.446* 
AD .031 .173 .159 .257 .056 -.004 .026 
Values as expressed in Pearson’s correlation coefficient scores. * Denotes that the correlation is significant at the 0.05 level. ** Denotes that the 
correlation is significant at the 0.01 level. Significant correlations after correction for multiple comparisons are highlighted in bold.  bvFTD = 
behavioural-variant frontotemporal dementia; AD = Alzheimer’s disease. Statistical significance was set at p < .007 Bonferroni corrected for 
multiple comparisons.  
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